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Enacyloxin is an antibiotic synthesized inside bacterial cells by gigantic modular multienzyme 
complex called polyketide synthase (PKS), which is active against multidrug-resistant 
Acinetobacter baumannii that leads the World Health Organization ‘priority pathogens’ list. In 
spite of its promising physiological activity, enacyloxin IIa has not been used as a drug due its 
structural instability. The modular nature of enacyloxin and other PKSs makes them amenable 
to rational engineering to elucidating protein-protein interactions within PKSs will be crucial 
for their bioengineering to produce novel drugs. 
A key step in enacyloxin biosynthesis is the transfer of the polyketide chain from an acyl carrier 
protein (ACP) domain in the last PKS module to a standalone peptidyl carrier protein (PCP) by 
a non-elongating ketosynthase (KS0) domain. It has been reported that this transfer is 
necessary for the condensation (C) domain to catalyse polyketide chain release via 
intermolecular esterification with 3, 4-dihydroxycyclo-hexane carboxylic acid (DHCCA). No 
esterification occurs when the substrate is attached to the ACP domain. Thus, the KS0 transfers 
the substrate from a carrier protein that is unable to interact with the C domain to one that it 
is able to interact with. 
An experimental approach combining NMR and biochemical techniques presented in the thesis 
suggests that the length of helix 1 and the lack of charged residues in the C-terminal part of 







Chapter 1. Introduction 
 
1.1 Natural products 
 
Natural products are substances of a great structural variety and with a molecular weight 
normally below 3000 Daltons (Figure 1.1)1.  
Within the field of organic chemistry, natural products are usually defined as 
purified organic compounds isolated from natural sources that are produced by 
the primary or secondary metabolic pathways2. However, within the field of medicinal 
chemistry, the definition is often restricted to secondary metabolites3. Unlike primary 
metabolites, secondary metabolites are not necessary for an organism to live, grow, 
develop or reproduce. Rather, they are produced as a consequence of the organism 
adapting to the surrounding environment to act as a mechanism of defence against 
predators and to compete for space and nutrients4.   
Natural products and their derivatives have been used as a source of therapeutic 
remedies for millennia, dating back to ancient Mesopotamia. However, the first 
antibacterial microbial natural product, penicillin, was discovered by Alexander Fleming 
in 1928. The period that followed was a golden age of drug discovery which resulted in 
the discovery of many natural products and their development into drugs5 (Figure 1.1). 
The introduction of antibiotics such as tetracycline and kanamycin has significantly 






Figure 1.1 Examples of natural products with antibacterial properties. 
 
Although natural products have been crucial in drug discovery, pharmaceutical 
companies have either terminated or substantially reduced their natural product 
research in the past few years6. The reasons for this were the progress in metagenomics 
and combinatorial chemistry. Moreover, not all natural products can be completely 
synthesized due to their structural complexity. The synthesis of such compounds on an 
industrial scale would be expensive and time consuming. 
However, with the help of advances in drug discovery and increased medicinal chemistry 
knowledge, pharmaceutical and biotechnology industries are once again turning to 
natural products to harness new useful derivatives of these therapeutics7. This is often 
driven by the therapeutic need to treat complicated conditions such as cancer and 
infections initiated by multi-resistant pathogens. Moreover, the treatments against an 





1.2 Antimicrobial resistance (AMR) 
   
The misuse and overuse of antibiotics in farming and agriculture has allowed pathogenic 
bacterial strains to acquire resistance, which has become an increasing problem in recent 
years. At the same time, the pace at which novel antibiotics are being discovered has 
reduced considerably. It is not just a problem limited to bacteria, but all microbes that 
have the potential to mutate and make drugs ineffective. The progress made over the 
past few decades to manage diseases such as malaria and HIV could be reversed, with 
these conditions once again spiralling out of control. It is thought that over 70% of 
pathogenic bacteria are resistant to at least one antibiotic. For instance, in 15 European 
countries, more than 10% of bloodstream Staphylococcus aureus infections are caused 
by methicillin-resistant strains (MRSA), with several of these countries seeing resistance 
rates closer to 50%8. Also, colistin, discovered in the 1940s, was rarely used due to many 
negative side-effects and remained an effective last resort antibiotic. However, over the 
past few years, numerous cases of genes that confer colistin resistance through 
horizontal gene transfer have been found, including cases in the UK and US9. 
Transduction, a horizontal gene transfer mechanism mediated by bacteriophages that 
infect bacteria, is thought to be the primary means by which bacteria acquire resistance 
to antibiotics. 
With globalisation increasing the spread of the disease, it is now imperative to produce 
novel drugs. This has led to the World Health Organisation (WHO) categorising AMRs as 
a severe threat to global public health. 
 
1.3 Enacyloxin IIa 
 
One of the antibiotics that could overcome current antimicrobial resistance is enacyloxin 
IIa, which is synthesized by Burkholderia ambifaria, a bacterial strain which can cause 
severe lung infections in people with cystic fibrosis10. Enacyloxin IIa is effective against 
Acinetobacter baumannii, known as one of the most difficult multidrug-resistant gram-
negative bacilli to control11. Acinetobacter species is associated with nosocomial 
infections including pneumonia, septicemia, wound sepsis, urinary tract infection, 
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endocarditis, and meningitis12. A. Baumannii has become an emerging pathogen 
especially in the hospitals due to its ability to survive in adverse environmental 
conditions13. 
Therefore, it is categorised as a priority pathogen on the 2017 WHO’s list of bacteria for 
which new antibiotics are urgently needed. Enacyloxin IIa is a polyene polyketide, which 
is a class of natural products that are synthesized by a polyketide synthase biosynthetic 
gene cluster (Figure 1.2). Polyketide synthases are described later in the chapter. Unlike 
usual polyenic antibiotics that break down the cell membranes of yeast and fungi, 
enacyloxin IIa interferes with protein synthesis by targeting elongation factor Tu (EF-Tu), 
a crucial mediator of translation at the ribosome14. The prokaryotic EF-Tu binds 
aminoacylated tRNA and moves it onto a free site on the ribosome to associate with the 
mRNA, followed by guanosine triphosphate (GTP) hydrolysis into guanosine diphosphate 
(GDP) if the match is correct.  Bound to ET-Tu GTP, enacyloxin IIa inhibits EF-Tu release, 
thus blocking the transfer of polypeptide-tRNA complex of the ribosomal P site onto the 




Figure 1.2 Enacyloxin IIa – the structure and mode of action. The figure shows the crystal 
structure of the Escherichia coli EF-Tu·guanylyl iminodiphosphate (GDPNP)·enacyloxin IIa 
complex and the bound enacyloxin IIa. Elongation factor (EF-) Tu·GTP transfers aminoacyl-
tRNA to the ribosome. Enacyloxin IIa hinders bacterial protein synthesis by blocking the 




In spite of its favourable antimicrobial properties, enacyloxin IIa is not stable enough to 
make a good drug candidate. For example, the ester bond (Figure 1.2) can be easily 
hydrolysed in the body and unstable conjugated double bonds are complicated to isolate. 
Besides, its complex structure renders the in vitro synthesis difficult. However, using 
synthetic biology approaches, it might be possible to manipulate enacyloxin IIa 
biosynthesis to create pharmaceutically useful products. 
 
1.4 Polyketide synthases and non-ribosomal polyketide synthases 
 
Enacyloxin IIa is biosynthesized by a giant bacterial multi-enzyme complex which is a 
hybrid of a large biomolecular complex called polyketide synthase (PKS) and 
nonribosomal peptide synthetase (NRPS). The enacyloxin synthetic pathway is described 
later in this chapter. Polyketides are a family of bioactive natural products that have 
found widespread commercial application in pharmaceutical and agrochemical 
industries. Polyketides are biosynthesised by enzymes called polyketide synthases (PKSs) 
that are organised as a series of modules comprised of linked domains. Due to their 
modular organisation, PKSs represent targets for bioengineering, enabling the synthesis 





Figure 1.3 Examples of natural products produced by bacterial PKSs.The natural products 
produced by NRPSs differ from PKS synthesised products as they are synthesized from 
proteinogenic and non-proteinogenic amino acids. Some of the compounds presented in 
the figure are used clinically as antibiotics (erythromycin, amphotericin B,gramicidin), 
lipid-lowering drugs (lovastatin), immunosuppressants (cyclosporin) and to treat cancer 
(bleomycin). Gladiolin has a promising activity against Mycobacterium tuberculosis. 
 
1.4.1 Polyketide biosynthesis 
 
The main building units of polyketides are acyl-CoAs. Their biosynthetic scheme 
resembles that of fatty acid synthases (FASs)16. In both polyketide and fatty acid 
biosynthesis, the growing chain is covalently attached to an acyl carrier protein (ACP) via 
a phosphopantetheine (PPant) arm17,18. The PPant, derived from CoA, is attached post-
translationally to a conserved serine residue on the apo-ACP by a phosphopantetheine 
transferase (PPTase) to yield holo-ACP (Figure 1.4.)19,20. Conversion from apo to holo-ACP 
is important for the bioactivity of ACP as the newly synthesized ACP is in the form of apo-
ACP, which is a non-functional form of the protein that cannot transfer the substrate and has 





Figure 1.4 Conversion from apo-ACP to holo-ACP. Catalysed by a PPTase, 
phosphopantetheine is posttranslationally attached from co-enzyme A to a conserved 
serine residue on an apo-ACP. 
 
The holo-ACP, together with an acyltransferase (AT) and a ketosynthase (KS), comprise 
the minimal set of enzymatic domains required for a single chain elongation reaction, 
also being called a module (Figure 1.5). Polyketide biosynthesis is initiated by the loading 
of a starter unit, an acyl-CoA derivative, onto the Ppant arm of the ACP. 
In fatty acid biosynthesis, the starter unit is typically an acetyl, whereas PKSs can use 
several variants such as acetyl-, propionyl- and butyryl23. AT domain catalyses the transfer 
of a malonyl-derived extender unit from a CoA-thioester onto the thiol of the ACP 
phosphopantetheine moiety24. The elongating carbon-carbon bond is then formed by 
Claisen condensation, which is catalysed by the KS domain (Figure 1.5.). Further 
modifications are generated at the β-keto position by ketoreductase (KR), dehydratase 
(DH) and enoyl reductase (ER) domains, to form β-hydroxyl and fully saturated 
intermediates 23.  
The growing polyketide chain is transferred from the ACP to the KS of the downstream 
module, where further elongation and modification is carried out. The polyketide chain 
is therefore shifted from module to module until the final polyketide structure is 
assembled. Following the last elongation cycle, typically, a thioesterase (TE) domain 





Figure 1.5 The mechanism of polyketide chain formation. The enzymatic domains required 
for a single cycle of chain elongation are KS, AT and ACP (acyl carrier protein) (‘minimal 
module’).  AT domains loads malonyl-derived precursors onto the thiol of the ACP. 
 
The released polyketide chain is usually only a precursor to the bioactive compound. 
Tailoring enzymes are required to produce the final product by adding modifications, 
including glycosylation, methylation and hydroxylation23. 
 
1.4.1.1 Polyketide synthase classification 
 
PKSs can be divided into three classes based on their modular architecture and mode of 
action26,27. Type I PKSs are primarily found in bacteria and fungi, whereas type II PKSs only 
in bacteria. Type III PKSs are mainly observed in plants. The type I PKSs can be sub-divided 
into the iterative type I PKSs, which are found in both bacteria and fungi, and the modular 
type I PKSs can be only found in bacteria. 
 
Iterative Type I PKSs 
 
Iterative type I PKSs make use of a single module to carry out elongation steps. β-keto 
processing is dictated by the reductive domains within the module, generating non-
reducing (NR), partially reducing (PR) and highly reducing (HR) products. Despite being 



























Modular Type I PKSs 
 
Modular type I, or non-iterative PKSs, are comprised of multiple sequential modules 
which produce the polyketide product. Each module catalyses a single cycle of chain 
elongation28. A complete modular type I PKS complex usually consists of two or more 
large polypeptide chains which leads to overall molecular weights on the MDa scale. The 
6-deoxyerythronolide B synthase (DEBS) system, responsible for the biosynthesis of an 
antibiotic erythromycin A (the chemical structure is shown in Figure 1.2), is a prototypical 
example of such a PKS29,. Here, the biosynthesis is initiated by the loading of a propionyl 
unit onto the first ACP by a loading module consisted of an AT and an ACP. The 
subsequent AT domains load methylmalonyl extender units onto the ACPs for chain 
extensions. After six successive chain elongations, a TE domain catalyses the 
macrolactonisation of the polyketide chain, which results in the release of the product 6-
deoxyethronolide B, which is a precursor of erythromycin (Figure 1.6). 
The modular nature of PKSs and sequential modifications of the intermediates in modular 
type I PKS systems allow prediction of the final product from the understanding of the 
domain order. This relation between domain architecture and the final product is 
referred to as colinearity17. By understanding domain organisation, it was possible to 






Figure 1.6 Modular organisation of a prototypical PKS system – DEBS. The biosynthetic 
gene cluster of Saccharopolyspora erythraea contains three large open reading frames – 
DEBS1, DEBS 2, DEBS3, which code for three polypeptides30. Each DEBS polypeptide is 
comprised of functional domains that are shown are shown, along with intermediate 
polyketide chains produced. Stepwise synthesis of 6-dEB begins at DEBS1 and ends with 
cyclization by the TE domain to yield 6-dEB, which is further functionalized (not shown) to 
yield erythromycin.  
 
 
Cis- and trans-AT PKSs 
 
Cis- and trans- class of modular type I PKSs do not follow collinearity rule since their 
domain organisation does not always correlate with the product due to the high diversity 
of modules that often contain novel enzymatic domains33. The most characteristic 
feature of trans-AT PKSs is the absence of AT domains whose activity is provided by free-
standing domains servicing every module in the entire cluster34. In cis-AT PKS, the AT 
domains are integral to the PKS, with an AT domain within each module.  
  






















































Type II PKSs 
 
Type II PKSs adopt an iterative mechanism. However, unlike iterative type I PKSs, their 
catalytic domains are expressed on different genes. Type II PKSs are composed of 
separate functional enzymes that interact during synthases to form a polyketide 
structure. The polyketide structure is then enzymatically converted to the cyclic form to 
produce polycyclic aromatic compounds such as an antibiotic tetracycline and a 
chemotherapy drug doxorubicin. 
Characteristic of type II PKS group is the core module of subunits called ‘minimal PKS’, 
which is comprised of an ACP, a malonyl-CoA:ACP transacylase (MAT) and two KS 
domains; KSα and KSβ, where KSβ dictates the length of the polyketide chain35. For that 
reason, KSβ is called chain length factor (CLF). The final product is formed by the 
additional domains including ketoreductases (KR), cyclises (CYC) and aromatases (ARO). 
 
Type III PKSs 
 
The type III PKSs have the simplest domain structure which includes homodimers of 
relatively modest-sized proteins (40–45 kDa). They catalyse the assembly of polyketides 
by iterative decarboxylative malonyl-CoA condensations, in a biosynthetic process that 
closely resembles biosynthesis of fatty acids, but without the presence of acyl carrier 
proteins (ACPs). The chain elongation of a CoA-tethered starter molecule is typically 







Figure 1.7 Biosynthesis of rhodomycin, an example of an iterative type II PKS. The figure 
shows a mechanism of 2-carbon decaketide chain synthesis to produce ε-rhodomycinone, 
the doxorubicin precursor. The doxorubicin PKS condenses one propionyl-CoA unit and 
nine malonyl-CoA units. Initially, KS, CLF, and ACP  catalyze a formation of a diketide 
between propionyl-CoA and malonyl-CoA. The same domains catalyze eight more 
condensation reactions, starting with the previous diketide and adding successive malonyl 







Figure 1.8 Schematic representation of a type III biosynthetic mechanism, as exemplified 
by the RppA synthase for the biosynthesis of aromatic polyketide flavolin.39 The figure was 
reproduced from Shen, 2003. 
 
1.4.1.2 Structure and mechanism of PKS domains 
 
Core PKS domains are mechanistically and structurally relatively well understood so their 
structural features will be discussed below.  
 
The ketosynthase domain 
 
The ketosynthase (KS) domain catalyses the carbon-carbon bond forming thioester-
templated Claisen condensation reaction required for the chain elongation step in 
polyketide and fatty acid biosynthesis40. Catalysis is initiated when an intermediate is 
transferred through transthioesterification from the ACP of one module to the KS of the 
next module. An ACP with an attached extender unit then binds to the polyketide-bound 
KS to allow for a decarboxylative condensation. This generates a β-keto intermediate that 
can be processed at its α- and β-carbons by methyltransferase (MT), ketoreductase (KR), 
dehydratase (DH), enoylreductase (ER), or β-branching enzyme34. 
Crystal structures of KS domains from both FASs and PKSs exhibit a highly conserved 2α-
5β-2α-5β-2α thiolase fold (Figure 1.9.A and B)41,42. KS domains are generally dimeric, and 
their interface regions contribute significantly to the dimerisation of the type I PKSs. The 















































Figure 1.9 Structural analysis of the ketosynthase from module 1 of the bacillaene 
synthase43 (PDB: 5ELP). A) KS dimer with a highlighted  2α-5β-2α fold and and  active site. 
B) Close-up of the 2α-5β-2α fold. C) A His-His-Cys catalytic triad is typical of KS from most 
organisms. 
 
The insights into both processes have been obtained from crystal structures of a FAS KS 
and E.coli FabF with platensimycin44,30. These structures suggested that the oxyanion hole 
stabilises the acyl-KS. Oxyanion hole is formed by the amide hydrogens of the active site 
Cys and a conserved Phe, which is believed to mediate the acylation of the active site 
Cys45. The crystal structure of platesimycin-FabF complex revealed that the carbonyl of 
the glutamine side chain was hydrogen-bonded to the two backbone amides in the 
oxyanion hole46. This led to conclusion that only one of the His residues is catalytically 
important in the activation of the carboxylate extender unit. Another histidine is thought 
to act as a base which activates a water molecule to facilitate nucleophilic attack on 
carboxylate47. It is believed that the coordination of the carbonyl in the oxyanion hole 
facilitates the organisation of active site residues to perform decarboxylation and 
elongation48. 
The KS mode of action (Figure 1.10) involves acylation where the thioesterification starts 
when an acyl-ACP enters the KS substrate-binding. There is also a phosphopantetheine-
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binding area inside KS. The amino acid sequence of phosphopantetheine-binding region 
is well conserved, but the structure of the substrate-binding area has not been yet 
characterised. The pKa value of the active site cysteine is low for a thiol due to its positive 
charge34 which increases the nucleophilicity of its thiol, enabling attack of the carbonyl. 
The resulting negative charge on the thioester carbonyl is stabilised by an oxyanion hole. 
The intermediate then releases the Ppant-ACP, which leaves the growing polyketide 
chain attached to the KS. The next step involves the decarboxylation of the malonyl or 
methylmalonyl chain extender unit that is supplied by the upstream ACP. Upon binding, 
a water molecule that is activated by one of the catalytic histidine residues facilitates the 
attack at the malonyl carboxylate, which releases HCO3ˉ. The resulting enolate is 
stabilised by a conserved histidine residue. The last condensation step involves the 
enolate-mediated attack on the acyl-thioester. The resulting tetrahedral intermediate is 
stabilised by the oxyanion hole. This is followed by the formation of a β-keto product. The 
elongated intermediate is linked to the receiving ACP and is diffused out of the active site. 
 
Non-elongating ketosynthase domains 
 
The variants of KS are sometimes employed by the domains to fulfil specific functions 
within the biosynthetic cluster, such as the non-elongating KS domains, called KS0. These 
domains lack a crucial conserved active site histidine, which is required for chain 
elongation49. It is believed that they function only as a shuttle to pass the intermediates 
onto the next module or to allow modification from a downstream domain without any 
chain elongation occurring19.  
However, non-elongating ketosynthases play important roles in PKSs by catalysing 






Figure 1.10 Schematic representation of a proposed mechanism for the ketosynthase 
mode of action. The initial step involves the transfer of the acyl group to the acyl-ACP 
active site cysteine. Backbone amides of Phe and Cys form the oxyanion hole, which 
neutralizes the thioester carbonyl negative charge. Malonyl-ACP binds to the enzyme 
upon the release of ACP. Histidine activates a catalytic water molecule to release 
bicarbonate by attacking the malonyl-ACP carboxylate. Finally, -ketoacyl-ACP product is 
formed. The figure was reproduced from Zhang, Y. et al, 2006.  
 
The acyl carrier protein 
 
Acyl carrier proteins (ACPs) typically consist of four -helices connected by three loops 
that are stabilised by a hydrophobic core (Figure 1.11.)52–55. The conserved serine, 
located at the N-terminal side of helix II, is post-translationally modified to incorporate 
an ~18Å long phosphopantetheine chain. Phosphopantethiene moiety is an essential 
prosthetic group of ACP, as it mediates covalent attachment of the intermediates to the 
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PKS via a thioester linkage thus providing the required flexibility to reach active sites of 
other domains within a given module56. 
  
 
Figure 1.11 The NMR structure of B. subtilis apo-ACP (PDB: 1HY8). Conserved serine 
residue is highlighted in red. 
 
Specific type I PKS ACPs (EryACP2) have a short N-terminal helix (helix 0) and it is believed 
to facilitate the docking to downstream KS domains19. ACPs transfer acyl groups to the 
KS domains that are immediately downstream, which implies that interactions between 
helix II of ACPs and KS domains are highly specific57. Crystal structures of ACPs from type 
II FAS indicate that the fatty acid acyl chain binds between the helices of the ACP 
domain19. This substrate sequestration can lead to minor alterations in ACP structure due to 
the perturbation of the helical core of the ACP by the substrate58.  This is not believed to be 
the case for type 1 ACPs, as suggested by the NMR studies of the acyl-ACP from the 
curacin cluster19.  
 
Protein-protein interfaces within type I PKS subunits 
  
The crystal structures of KS-AT didomain, DH, ER-KR and a TE, together with NMR 
structures of ACPs provided details about the boundaries between domains within 
PKSs19,59–63.  
In type I PKSs, the dimerization of the modules is mediated by the KS, which has a large 
dimeric interface in comparison to that of ACPs64. The other domains that commonly 
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establish an intermodular contact are the DH and TE. However, they also have a smaller 
interface than the KS domains64. AT, KR, ER and ACP are primarily monomeric. This allows 
the flexibility for the conformational changes required for PKS functions.  
In PKSs the dimers are often stabilised by dimerization motifs located at the ends of the 
modules. The motifs that facilitate KS and DH dimerisation include a coiled-coil that is 
frequently located at the N-terminal end of a PKS module and a four-helix bundle often 
present at the C-terminus.65–68.  
 
Structure of the Type I PKS complex 
 
In recent years, the understanding of type I PKSs structure has significantly improved with 
the progress in electron microscopy. EM revealed the quaternary structure of the dimeric 
metazoan69 and porcine70 FAS. The first details about KS-AT and KR interdomain 
boundaries were obtained from erythromycin PKS62. Although the type I PKSs share a 
large amount of structural similarity with the FAS, there are some differences between 
them. Compared to the dimeric FAS ER, the ER domain in type I PKSs is monomeric. These 
domain-domain structures of PKSs were generated by using NMR and X-ray 
crystallography so they have limitations due to differences in the oligomeric state and 
structure of individual catalytic domains. However, the recent advances in cryo-EM 
technology led to the first structural insights into the catalytic rearrangements of an 
intact PKS module. The models of the last module of pikromycin PKS (PikAIII) were 
acquired for each conformation of its catalytic cycle71. The study showed that KS, AT, and 
KR domains form a chamber. The dimeric apo-PikAIII was observed in two conformations. 
In the first conformation, ACP was located inside the chamber and interacted with the KR 
domain (Figure 1.12 1A, B). In the second conformation, it was near the KS and AT 
domains (Figure 1.12 2A, B). The removal of ACP resulted in a rotation of the KR domains 
around the AT domains which suggested that ACP plays a role in the positioning of the 
KR relative to the AT domain. Also, the study demonstrated that the upstream ACP binds 
to the KS domain outside PikAIII’s chamber. Furthermore, loading of a methylmalonyl 
extender unit onto PikAIII resulted in the ACP relocating to a second interaction site on 
the KS, this time inside the PikIII chamber. This provided evidence that the KS has two 
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Figure 1.12 Cryo-EM structures of holo-PikAIII71.  Solid (1A) and transparent (1B) 
representations with modelled structures of the cryo-EM map of holo-PikAIII 
conformation, in which the ACP5 (orange) is near KR5. Solid (2A) and transparent (2B) 
representations with moddele structures of the cryo-EM map of holo-PikAIII conformation 
in which ACP5 (orange) is near AT5. The figure was reproduced from Dutta et al., 2015.  
 
1.4.2 Non-ribosomal peptide synthases 
 
Non-ribosomal peptide synthases (NRPS) are, similarly to modular type I PKSs, modular 
megasynthases responsible for the production of secondary metabolites in bacteria and 
fungi. However, NRPSs produce metabolites by linking proteinogenic and non-
proteinogenic amino acid units. 
NRPS biosynthesis is mediated by a carrier protein-tethered thioester which activates the 
acyl group of each monomer unit and transfers the elongated chain between catalytic 
domains, whereas PKSs use malonyl-derived units to synthesize polyketide chains. 
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A minimal NRPS module consists of an adenylation domain (A), condensation domain (C) 
and a peptidyl-carrier protein (PCP)72. Firstly, the adenylation domain activates the 
carboxyl region of the amino acid with ATP, forming the acyl-phosphoric acid anhydride 
with AMP. This is followed by loading onto the phosphopanthetheine moiety of the PCP. 
The condensation domain then catalyses the nucleophilic attack of the amino group of 
the previously activated amino acid to the carbonyl of the tethered acyl group from the 
previous module. This results in the formation of a new peptide bond between the two 
units (Figure 1.11.)73. Additional (optional) domains can be incorporated into a module 
for further modification to the intermediate. For example, a cylisation (Cy) domain can 
be used to produce thiazoline or oxazoline intermediates, which can be further modified 
by an oxidation (Ox) domain to yield the thiazole and oxazole products. Epimerization or 
E domains are among the most abundant modification domains in NRPSs and they 
catalyse the stereochemical inversion of L-amino acids to D-amino acids. (TE) domain 




Figure 1.13 Schematic representation of NRPS domains mechanism.  
 




Condensation (C) domains represent a versatile class of NRPS domains. Any NRPS 
composed of more than one module contains at least one C-domain. However, single 
modular NRPSs may include C-domains, especially if they cooperate with other NRPSs. 
The primary target of a C-domain is the condensation of the upstream and downstream 
activated substrates through a nucleophilic attack, leading to the formation of a dipeptide 
and peptide chain elongation.  
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The C domain has two binding sites: one for the electrophilic donor substrate (the acyl 
group of the growing chain) and one for the nucleophilic acceptor substrate (the 
activated amino acid)37. Thus, it is accessible to substrates attached to 
the phosphopantetheine arms of both an upstream donor peptide carrier protein (PCP) 
and a downstream acceptor PCP. Also, several residues of the C-domain can fulfil multiple 
functions - condensation and epimerization, N-methylation, cyclization or serine-
dehydration.  
A channel running through the protein is formed at the interface of the two subdomains, 
starting near the floor loop of the C-terminal subdomain and ending near the helix α1 of 
the N-terminal subdomain with the conserved HHxxxD motif located at the midpoint of 
the channel (Figure 1.14)75. The PCP-C didomain structures reveal that the donor PCP is 
positioned on the C domain at the entrance near the floor loop76,77.  The structure of 
termination module from Acinetobacter baumannii suggests that the acceptor PCP 
delivers the substrate into the substrate channel form the entrance near the helix α1 of 
the N-terminal subdomain78. The second histidine of the conserved HHxxxD motif is 
proposed to play an important role in positioning the α-amino group 







Figure 1.14 The structure of NRPS condensation (C) domain VibH80. The figure was created 
from the PDB file 1L5A using Chimera. The residues shown were identified by mutagenesis 
to be important for C-domain catalyitic activity. His 126 is not crucial for VibH catalysis.  
However, this residue is required in other C domains. 
 
Peptidyl carrier proteins (PCPs) 
 
The NMR solution structures of PCPs reveal a four-helix bundle with an extended loop 
between the first two helices, resembling the overall fold of acyl carrier proteins (ACPs) 
from PKSs (Figure 1.11). Also, the conserved serine, which is the cofactor-binding site, 
has the same location as in the ACPs (Figure 1.15). PCPs are sometimes referred to as 
thiolation domains. An important difference between ACPs and most PCPs is the 
sequestration of acyl chains within the core of ACPs (i.e. type II ACPs), which has not been 
observed for the substrates bound to PCPs81,82. ACP sequestration of substrates requires 
interacting domains to utilize a chain flipping mechanism to allow the bound substrates to 






Figure 1.15 Structure of apo PCP1 from yersiniabactin synthetase (PDB: 5U3H). Conserved 
serine is highlighted in red. 
 
1.4.3 Hybrid NRPS-PKS systems 
 
The processive and modular biosynthetic logic of NRPSs and PKSs allows their integration into 
hybrid systems that are utilised by bacteria and fungi to synthesize natural products. Such 
systems are referred to as NRPS-PKS hybrids, and are responsible for the biosynthesis of many 
bioactive compounds, examples of which are shown in Figure 1.16. 
 
1.4.4 Engineering of modular PKSs and NRPSs 
 
The potential interchangeability of PKS and NRPS catalytic domains and direct 
communication between enzymes makes them an appealing target for combinatorial 
biosynthesis. Combinatorial biosynthesis generates novel molecules by mixing and 
matching parts of known natural products, manipulating the genes encoding the enzymes 
responsible for their biosynthesis and altering functional groups through the 
manipulation of biosynthetic enzymes. Thus, polyketides are now a major area of study 






Figure 1.16 Natural products synthesised by NRPS-PKS systems. Pederin is an antiumor 
agent. Fusarin is a mycotoxin that infects agriculturally important crops. Mycrocistins are 
hepatotoxins.  
 
One approach includes manipulation of individual PKS domains in active residues to 
adjust their substrate and stereochemical specificity. Secondly, switching one domain for 
another from the same or different PKS, or even altering entire modules might reduce or 
extend the elongating chain. Addition or removal of catalytic domains would affect 
substrate during elongation85. Domain exchange has already been obtained by swapping 
an AT in DEBS with an AT from the rapamycin PKS, which enabled the modification of all 
extender units incorporated into the erythromycin backbone86. However, numerous 
attempts to exploit PKSs for combinatorial biosynthesis have not been successful due to 
the lack of information about the structure, mechanism and structural dynamics of the 






1.5 Enacyloxin biosynthesis  
 
The proposed biosynthetic pathway for enacyloxin IIa is presented in Fig. 1.1711. It is 
produced by a hybrid of type I PKS and NRPS. The loading module in protein Bamb 5925 
consists of a MT domain, a GNAT domain (malonyl transferase/de- carboxylase from the 
Gcn5 histone acyltransferase family) and an ACP domain. ACP initiates the biosynthesis 
with a propionyl starter moiety. The chain elongation continues in for ten rounds of chain 
extension from PKS modules. The enacyloxin PKS modules belong to trans-AT PKS as 
many of these modules do not include AT domains. The polyketide chain release is 
mediated by a non-elongating KS0 within module 10. Module 10 belongs to the trans-AT 
PKS phylogeny. The enacyloxin intermediate is proposed to be transferred from the ACP 
of Bamb 5919, to the adjacent KS0. The substrate transfer continues from the KS0 domain 
to a downstream PCP domain. It is postulated that specific protein-protein interactions 
contribute to the directionality of this process. Chain release is accomplished by the 
condensation of the 3’-hydroxyl group of a shikimate derived dihydroxy-cyclohexane 
carboxylic acid (DHCCA) with the PCP-bound polyketide. The condensation reaction is 
catalysed by an NRPS-like C domain. The released intermediate then becomes the 
substrate for a series of tailoring enzymes (not shown in Figure 1.17) 
It has been shown in Challis laboratory that the transfer of the polyketide intermediate 
from module 10 ACP to KS0 is necessary for the C domain to catalyse polyketide chain 







Figure 1.17 Proposed pathway for enacyloxin biosynthesis. The chain termination is 
mediated by the acyl carrier protein in module 10 (M10), which transfers the substrate to 
PCP via KS0, which is also located in module 10. PCP then transfers the substrate to the 
condensation domain (C), which condenses the chain with DHCCA.  
 
1.6 The aim of the project and objectives 
 
As mentioned earlier in this chapter, enacyloxin IIa cannot be used clinically due to its 
structural instability. To create more stable and pharmaceutically useful enacyloxin IIa 
analogues, it might be possible to manipulate its biosynthesis by the approach based on 
mixing and matching components from different PKS and NRPS assembly lines. However, 
to harness enacyloxin IIa PKS-NRPS for that purpose, it is important to understand the 
molecular structures and dynamics responsible for the specificity of domain-domain 
interactions and directionality of biosynthesis. This is particularly important for the 
domains involved in controlling the crucial step of polyketide chain release where two 
separately assembled molecules are joined together through an ester bond. The ester 
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should be replaced by a more stable functionality, e.g. amide bond, for pharmaceutical 
applications.  
As mentioned in the previous section, the chain termination involves the unusual indirect 
transfer of the polyketide chain from the ACP in module 10 to the downstream PCP, 
which then delivers the substrate to the condensation domain using non-elongating KS0, 
instead of direct interaction between ACP and condensation domain (C) (Figure 1.18). 
Since non-elongating KS0 does not modify the polyketide chain, it acts only as a shuttle 






































As the chain termination process involves two surplus enzymes (KS0 and PCP) which do 
not elongate or modify the substrate, it was proposed that a series of compatible 
interactions takes place between ACP, KS0, PCP and C protein domains. Elucidating the 
molecular basis for product release from the enacyloxin pathway is thus important for 
the application of this unusual biosynthesis to synthetic biology approaches for novel 
antibiotic production. Generally, a major challenge for engineering biosynthetic 
pathways is developing a molecular-level understanding of domain-domain and protein-
protein interactions to facilitate efficient catalysis. The description of interactions during 
enacyloxin chain release could explain rules of interactions that could enable 
bioengineering of novel biosynthetic pathways, and describe unidentified features from 
characterised biosynthetic pathways.  
However, carrier proteins, consequently their complexes with KSs, are highly dynamic 
and challenging to crystallise and be studied by X-ray crystallography. On the other hand, 
NMR spectroscopy can provide the structural and dynamical insights required to 
understand which structural characteristics of enacyloxin PCP make it a preferable 
interacting partner with the condensation domain compared to ACP. Solution-state NMR 
can provide valuable information about domain-domain interactions. However, solution-
state NMR analysis becomes substantially difficult for biomolecules over 30 kDa. This is 
not a problem for the analysis of enacyloxin carrier proteins, however, it poses a problem 
for the characterisation of their complexes with KS0. There are no such size limitations 
placed for solid-state NMR. Hence, the overall aim of this project was the structural and 
dynamical characterization of the interactions of enacyloxin module 10 ACP and the 
downstream PCP with KS0 by the combination of solution and solid-state NMR, followed 
up by biochemical and biophysical methods. The initial objective was to overproduce and 
purify ACP, KS0 and PCP domains and confirm their bioactivity by mass spectrometry 
enzymatic assay. The second objective was to express isotopically labelled ACP domain 
to obtain NMR backbone assignments required to study its interaction with isotopically 
unlabelled KS0 domain by solution-state NMR titrations. The third objective was to 
overproduce and purify isotopically labelled PCP domain and study its interaction 
interface with the KS0 domain also by solution-state NMR titrations. The final objective 
was to investigate the interactions between ACP and PCP domains with KS0 by using solid-
state NMR spectroscopy. 
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Chapter 2. Materials and methods 
 
2.1 Instruments and equipment 
 
WPA CO8000 Cell density meter (Biochrom) was used to measure optical density of 
microbial cultures. NanoDrop Lite spectrophotometer (Thermo Scientific) was used to 
measure DNA and protein concentrations. A BioRad Power PAC300 was used for agarose 
gel electrophoresis. Mini-PROTEAN Tetra Cell System (BioRad) was used for SDS-PAGE. 
UHPLC–ESI–Q-TOF–MS was performed using the MaXis II (Bruker) mass spectrometer. 
Circular dichroism spectra were acquired on a JASCO 1500 instrument. Solution-state 
NMR spectra were obtained using Avance II-700 (Bruker). Solid-state NMR spectra were 
obtained using 500 MHz Bruker Avance III, Bruker 600 MHz Bruker Avance II+ and 700 
MHz Bruker Avance III HD spectrometers. ÄKTA Pure 15M (GE Healthcare Life Sciences) 
and ÄKTA Purifier 100 FPLC systems were used to purify proteins. 
Other instrumentation includes New Brunswick Scientific Innova 44 refrigerated 
incubator shaker, Astell compact top autoclave, Thermo Electron Corporation Heraeus 
Function Line incubator, Eppendorf Centrifuge 5804 R, Hitachi Koki model Himac CR22N 
High-Speed Refrigerated Centrifuge and Eppendorf™ 5424 Microcentrifuges. 
 
2.2 Chemicals and reagents 
 
General chemicals were purchased from Sigma-Aldrich, Thermo Fisher, Merck and VWR 
International. Ultrapure H2O (milliQ, Millipore) used for dilution was prepared by 





2.3 Expression hosts   
 
Table 2.1: Employed E. Coli strains 
 
2.4 Protein constructs 
 
The constructs for the expression of domains from enacyloxin biosynthetic pathway were 
produced by Dr. Paulina Sydor. Bamb_5919 ACP (shorter construct) was designed by Dr. 
Simone Kosol. 
 
2.5 Buffers and gels 
 
All buffers for FPLC protein purifications were filtered using 500 mL Steritop-GP 45 mm 
bottle top filter (0.22 M pore size, Merck Millipore). If required, antibiotics ampicillin 
(100µg/ml) and kanamycin (50 µg/ml) were added to media. 
 
Table 2.3 Buffers and gels used in this work 
1% agarose gel 1 g agarose, 10 mL 10X TBE buffer, 90 mL H2O, 5 L 
of GelRed Nucleic Acid Stain (Biotium)  
10X Tris-borate-EDTA (TBE) electrophoresis 
running buffer 
108 g Tris-HCl, 55 g boric acid, 20 mL 1 M EDTA 
LB medium (1 L) 25 g Lysogeny Broth, Miller (Thermo Fischer) 
LB agar (1 L) 25 g Lysogeny Broth, Miller (Thermo Fischer), 15 g 
Bacto agar (Sigma-Aldrich) 
10xM9 salt solution (1 L) 64 g Na2HPO4  7H2O, 12 g KH2PO4, 5 g NaCl 
M9 minimal media (1L) 100 mL 10X M9 salt solution, 2 mL 1M MgSO4, 100 
µL 1 M CaCl2, 10 mL mL MEM vitamin solution 100X 
(Gibco®), 1000x micronutrient stock solution,  
Strain Manufacturer Genotype Description 
One shot TOP 10 Invitrogen F-mcrA (mrr-hsdRMS-mcrBC) 
80lacZ M15 lac74 nupG 
Plasmid propagation.  
 
One shot BL21 
Star (DE3) 
Invitrogen F-ompT hsdSB (rB-
,mB) galdcmrne131 (DE3) 
Protein expression  
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1000x micronutrient stock solution (50 mL) ammonium molibdate (3·10-6 M), boric acid (4·10-4 
M), cobalt chloride (3·10-5 M), copper sulphate 
(1·10-5 M), manganese chloride (8·10-5 M) and zinc 
chloride (1·10-5 M 
Na2+ -affinity loading buffer  50 mM Tris-HCl, 300 mM NaCl (pH=8.0) 
Na2+ -affinity elution buffer 50 mM Tris-HCl, 300 mM NaCl, 500 mM imidazole 
(pH=8.0) 
SEC purification buffer  20 mM Tris, 150 mm NaCl, pH=8.0 
Analytical SEC purification buffer 50 mM NaPi, 100 mM NaCl, pH=7.0 
Laemmli resolving gel (12%, 5 mL) 880 L H20, 2 mL 29:1 (30%) 
Acrylamide:Bisacrylamide, 1.04 mL Tris buffer (pH 
8.8, 1.5 M), 50 L 10% SDS, 50 L 10% ammonium 
persulfate, 2 L TEMED  
Laemmli stacking gel (12%, 1 mL) 680 L H20, 170 L 29:1 (30%) 
Acrylamide:Bisacrylamide, 130 L Tris buffer (pH 
8.8, 1.5 M), 10 L 10% SDS, 10 L 10% ammonium 
persulfate, 1 L TEMED  
10X SDS-PAGE (protein gel) running buffer  30 g Tris-HCl, 144g Glycine, 10 g Sodium dodecyl 
sulfate, H2O added up to 1L 
6X SDS-PAGE loading dye 2 mL 1 M Tris-HCl pH=6.8, 2 mL glycerol, 
0.4 mL -mercaptoethanol, 0.02 g bromophernol 
blue, 0.4 g sodium dodecyl sulfate, 2 mL H2O 
NMR buffer 50 mM NaCl, 100 mM NaH2PO4 · 7H2O, 10% (v/v) 
D2O, adjusted to pH=7.0 
 
2.6 Molecular Biology 
 
Preparation of chemically competent cells 
 
All proteins were recombinantly overexpressed using One Shot® BL21 StarTM (DE3) strain 
of E. coli. Plasmids were produced in the One Shot® TOP 10TM strain. All strains of E. coli 
were produced in the lab from commercially available stocks (Table 2.1). 1 µL of frozen 
E. coli stock was used to inoculate LB (10 mL). 2 mL of the overnight culture (37°C, 180 
rpm) was then used to inoculate 100 mL of LB and grown at 37°C, 180 rpm until the OD600 
~ 0.4 was reached. Cells were transferred into 50 mL Falcon tubes and left on ice for 20 
minutes. They were recovered by centrifugation at 3000 rpm, 15 min, 4°C. The pellet was 
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resuspended in ice-cold 0.1M CaCl2 buffer (10 mL per 1L of culture) and left on ice for 30 
minutes. The cells were then centrifuged (3000 rpm, 15 minutes, 4°C). The pellet was 
resuspended in ice-cold buffer (0.1M CaCl2 with 15% glycerol, 1 mL per 100 mL culture). 
After being left on ice for 5 minutes, 50 µL aliquots were flash frozen and stored at -80°C. 
 
Transformation of chemically competent E. coli  
 
Aliquots of competent cells were gently mixed with 1 µL of target plasmid-DNA (100-150 
ng/µL) and incubated on ice for approximately 20 minutes. The heat-shock was initiated 
at 42 °C for a period of 45 seconds. After 5 minutes on ice, 200 µL of LB medium were 
added. Cells were incubated for 1 hours at 37 °C, 180 rpm. Different volumes of cell 
suspensions (10-100µL) were dispersed on LB agar plates with relevant antibiotic 





Resulting colonies were picked and used to inoculate 10 ml of LB. The cultures were 
incubated overnight (37C, 180 rpm) and harvested by centrifugation (4000 rpm, 15 
minutes). Plasmid isolation was then carried out using GeneJET Plasmid Miniprep Kit 
(Thermo Scientific). The concentration of the purified DNA solution was determined by a 




Purity of the plasmid DNA was assessed by agarose gel electrophoresis. 1% w/v agarose 
gels were prepared in TBE electrophoresis buffer by heating the mixture in a microwave 
oven. After the agarose had dissolved and the solution cooled, GelRed was added (5 μl 
per 100 ml). 2 μl of the DNA loading dye 6x (Thermo ScientificTM) were added per 10µL 
of the sample before loading the gel (Table 2.3). The DNA was subjected to 
electrophoresis at 100 V for 60 minutes. Estimation of DNA length was done with the aid 




2.7 Protein expression, purification and characterization 
 
Overproduction and purification of proteins in LB media 
 
Protein expression always started with freshly transformed E. coli BL21 Star DE3 cells 
(Table 2.1) that were plated overnight (37C). The colonies were used for inoculation of 
5 mL pre-culture. The culture was grown overnight (37 °C, 180 rpm) and was used to 
inoculate 1L of LB which was grown to OD600 ~ 0.6 (4 to 5 hours, 37 °C, 180 rpm). 
Expression was induced by addition of 1 mM IPTG at an OD600 of 0.6-0.8. The incubation 
at 15-18 °C was proceeded overnight.  
 
Expression of isotope labelled proteins 
 
For the expression of 15N and 13C15N-labelled proteins, BL21 Star DE3 cells (Table 2.1) 
were first grown in 2 x 1 L of LB medium at 37 °C to an OD600 > 1.0. The cells were pelleted 
by centrifugation at 4,000 g for 15 minutes and washed with M9 salt solution (Table 2.3). 
Centrifugation step was repeated and the pellet resuspended in 20 mL of M9 medium 
supplemented with 15NH4Cl and [U-13C]glucose (Sigma Aldrich). Resuspended cells were 
used to inoculate 1L of M9 medium. After incubation for 1 hour at 18 °C and 180 rpm, 
expression was induced with 1 mM IPTG, and the culture was incubated at 18 °C 
overnight.  
 
Immobilised metal affinity chromatography protein purification 
 
Overnight media cultures containing overexpressed proteins were centrifuged (7000 g, 
20 minutes, 4°C). The resulting supernatant was loaded onto a HiTrap® Chelating Column 
(GE Healthcare), which had been pre-loaded with 100 mM NiSO4 and equilibrated in 
loading buffer (Table 2.3). Column-bound proteins were eluted in 2 mL fractions using 
elution buffer linear gradient from 10 mM to 500 mM imidazole. Protein containing 




Size exclusion chromatography (SEC) 
 
The final purification step involved separation of the proteins with respect to their 
molecular size by employing HiLoad® 16/600 Superdex® 200 pg (GE Healthcare) gel 
filtration column to purify Bamb_5919 KS0 and HiLoad® 16/600 Superdex® 75 pg (GE 
Healthcare) column for the purification of Bamb_5919 ACP and Bamb_5917 PCP. The 
samples were loaded on ÄKTA systems via 1 mL sample loop (GE Healthcare). The elution 
with SEC buffer (1.5 CV)  was performed at a flow rate of 1 mL/min (Fraction collector F9-
C, GE Healthcare). The eluted volume was collected in 1.5 mL fractions, which were 
analyzed by SDS-PAGE.  
 
Concentration and buffer exchange of protein samples by ultrafiltration 
 
Protein containing fractions were concentrated with Amicon centrifugal filters 
(Millipore). The MWCO was selected depending on the size of the protein (MWCO < 
MW/2). Small sample volumes were concentrated in centrifugal Amicon Ultra-0.5 filter 
units (Millipore). Centrifugal filters were also used for buffer exchange and desalting. 
 
Cleaving His-tags from proteins 
 
Green fluorescent protein tobacco etch virus (GFP-TEV) was used to cleave the His-tag 
from purified proteins. Proteins and GFP-TEV were mixed in approximately 5:1 ratio and 
were incubated for 2 hours at 30C to achieve the optimal TEV turnover rate88. TEV 
digested proteins were run through a Na2+-affinity column or HiLoad® 16/600 
Superdex® 75 pg (GE Healthcare) gel filtration column to remove remaining His-tagged 
proteins and GFP-TEV protease. The flow-through and fractions were collected and 
examined on an SDS-PAGE gel. Samples were then concentrated and stored. The plasmid 
containing TEV protease was obtained from dr. Muhammad Hasan. 
 
Analytical SEC for protein characterization 
 
Analytical Superdex® 200 Increase 10/300 GL column (GE Healthcare) was used to assess 
the molecular weight and the oligomeric state of Bamb_5919 KS0 and Bamb_5917 PCP in 
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NMR buffer (Table 2.3). The column was equilibrated with 2 CV of NMR buffer (Table 2.3). 
Protein samples were injected via 2 mL sample loop (GE Healthcare) and eluted at a flow 
rate of 0.75 mL/min. The mixture of standard proteins (Sigma Aldrich) was applied to the 
columns for calibration (Table 2.4). The observed retention volumes were correlated with 
the known molecular weights of standard proteins. Blue Dextran (Sigma Aldrich) was used 
for the determination of the void volume. Elution time of each marker is displayed in 
Table 2.3. 
 
Table 2.4 Protein standards used for calibration 
Protein marker Molecular weight (MW) Elution volume (mL) 
Thyroglobulin 660 9.09 
Apoferritin 443 9.99 
-amilase 200 11.77 
Bovine serum albumin (BSA) 66 13.84 
Lysozyme 14 20.04 
 
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) 
 
Polyacrylamide gel-electrophoresis (PAGE) was performed under denaturing conditions 
employing sodium dodecyl sulfate (SDS). Polyacrylamide percentage of 12% was used 
for analysis. Usually, 10 µL of protein samples and 25 µL of SDS-loading buffer (Table 2.3) 
were mixed and incubated at 95 °C for 5 min. 6 µL of sample was loaded into each lane 
of the stacking-gel.  
Electrophoretic separation of proteins was accomplished in a Mini-PROTEAN Tetra Cell 
System (BioRad) by applying a voltage of 180 V for 45 min in 1X protein running buffer 
(Table 2.3). Staining of gels was achieved by using InstantBlue Protein Stain (Expedeon). 
The used protein marker was PageRuler™ Prestained Protein Ladder (Thermo 
Scientific™). Gels were destained overnight in H2O. 
 




100 µL sample aliquots were flash-frozen in liquid nitrogen and stored at -80 °C. 
Bamb_5919 ACP  and Bamb_5917 PCP were stored in NMR buffer (Table 2.3) at the 
concentration of 500 µM. Bamb_5919 KS0 and Bamb_5919 ACP_KS0 were stored in NMR 
buffer with 10% glycerol at the concentration of maximum 50 µM to avoid protein 
precipitation.  
 
Determination of protein concentration 
 
The concentration of protein solutions was assessed by measuring the absorption of 
aromatic residues at a wavelength of 280 nm (A280nm). Drops of 3 µL were measured in 
triplicates using the NanoDrop 1000 spectrophotometer (Thermo Fisher Scientific). 
Extinction coefficients were obtained from the ExPASy ProtParam tool89 
Bamb_5919 ACP with the His-tag removed does not contain tryptophans and tyrosines 
so the sample concentration could not be accurately determined by using A280nm 
absorption. Hence, these samples were exchanged first to water (2 mL final volume), 
flash-frozen and freeze-dried at –60 °C and 0.1 mbar for 8 h (Virtis® Brand Benchtop(TM) 
'K' Freeze Dryer). Sample concentration was calculated based on the weighted protein 
mass. The dry protein powder was tightly sealed and stored at –80 °C. 
 
2.8 Homology modelling of Bamb_5919_ACP 
 
Homology model of ACP domain was constructed using the Phyre+ server90. The utilised 
template was the published structure 2JU291. The model was visualized using UCSF 
Chimera package92. 
 
2.9 Biochemical assays 
 
Phosphopantetheinylation of carrier proteins 
 
Apo-Bamb_5919 ACP and apo-Bamb_5917 PCP were converted to their holo forms by 
using phosphopantetheinyl transferase (PPTase) Sfp from B. subtilis. 400 µM of each apo-
protein was combined with 10 µM Sfp, 10 mM MgCl2 and 1 mM CoA per 500 µL of the 
reaction solution. Reactions were carried out for an hour at a room temperature in an 
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NMR buffer at pH=7.0. Phosphopantetheinylation was verified by UHPLC-ESI-Q-TOF-MS 
analysis (maXis II Bruker). The plasmid containing Sfp was acquired from Dr. Manuela 
Tosin. 
 
Acyl transfer assays 
 
Apo-Bamb_5917 PCP was converted to its holo form as described above. Apo-
Bamb_5919 was converted to its acetyl form by adding acetylCoA to the reaction mixture 
instead of CoA. Excess acetyl-CoA and CoA was removed by using Amicon Ultra 0.5 
centrifugal filters (3 kDa). Acetyl transfer reaction was initiated by incubating 100 µM 
holo-Bamb_5919 ACP and holo-Bamb_5917 PCP with 25µM holo-Bamb_5919_KS0. 
LC/MS experiments were performed using UHPLCESI-Q-TOF-MS analysis.  
 
2.10 Analytical techniques 
 
Circular dichroism (CD) spectroscopy 
 
CD spectra were recorded between 190 and 260 nm at room temperature a JASCO J-
1500 machine with a Peltier type cell holder (PTC-423L) using a 1-mm path length quartz 
cuvette, , with nine scans for data accumulation, a data pitch of 0.1 nm, band widths of 2 
nm and a scanning speed of 100 nm/min. 500 L (0.1 mg/mL) of protein samples were 
prepared in an NMR buffer (Table 2.2). The buffer was measured for baseline evaluation 
and correction. 
Melting curves were recorded in a temperature range of 20 to 90 °C. The temperature 
scan was performed in increments of 0.1 °C and with a heating rate of 1 °C/min. CD 
spectra were recorded at the initial and final stages of the temperature scans as well as 
at the initial 
temperature after the heating process to test for reversibility.  Spectral analysis was 
performed using DichroWeb 92 using SELCON3 method for fitting93. 
 
Ultra-high performance liquid chromatography coupled with electrospray ionization-




Protein masses and acyl-transfer assays were analyzed on a MaXis II (Bruker) ESI–Q-
TOF–MS connected to a Dionex 3000 RS UHPLC fitted with an ACE 3 C4-300 column (100 
× 2.1 mm). The column was eluted with a linear gradient of 5–100% acetonitrile 
containing 0.1% formic acid over 30 min. The mass spectrometer was operated in positive 
ion mode with a scan range of 200–3,000 m/z. Compass DataAnalysis 4.1 (Bruker) was 
used to extract ion chromatograms. 
 
Bio-layer Interferometry (BLI) measurements 
 
The presence of only one lysine residue in the His6-tag was exploited for biotinylation of 
the Bamb_5919 ACP and Bamb_5919 PCP domain using the EZ-link Sulfo-NHS-Biotin 
cross-linking reagent (ThermoFisher Scientific), which reacts selectively with primary 
amines. After incubation for 30 min at room temperature, non-reacted cross-linking 
agent was removed on ZEBA spin desalting columns (3K MWCO, ThermoFisher Scientific) 
before loading Streptavidin biosensors (Pall ForteBio) with the biotinylated apo-
Bamb_5919 ACP and apo-Bamb_5917 PCP domains at a concentration of 70 nM. The 
binding of Bamb_5919 KS0 in concentrations of 0.175, 0.35, 0.75, 1.55, 3.1, 6.25, 12.5, 
and 25.0 µM to the immobilized biotinylated carrier protein domains was monitored on 
an Octet RED96 System (Pall ForteBio) in triplicates, except for the binding of apo-
Bamb_5919 ACP and Bamb_5919 KS0. The sensor responses were fitted using the Octet 
Software. Affinity constants were extracted from steady-state fittings using the equation 
𝐵𝑚𝑎𝑥∗𝑋
(𝑋+𝐾𝑑)
, where X corresponds to the Bamb_5919 KS0 concentration and B is the measured 
response in nm. 
 
Isothermal titration calorimetry 
ITC experiments were performed using a Microcal ITC200 (Malvern) located in the 
Biomedical Isothermal Titration Calorimetry Facility (Division of Virology at 
Addenbrooke’s Hospital, University of Cambridge). The proteins were ran over a size-
exclusion column first to exchange the samples to the NMR buffer. Bamb_5919 ACP and 
Bamb_5917 PCP were directly titrated into the chamber containing 200 L of 25 μM 
Bamb_5919 KS0. The concentrations of Bamb_5919 ACP and Bamb_5919 PCP were 12.5 
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M, 6.25 M, 3.1 M, 1.55 M, 0.75 M, 0.35 M, 0.175 M. Nineteen 2 L injections 
were performed with a pre-injection of 0.2 L (total ligand volume of 38.2 L, 240 s 
injection intervals). The stirring speed was 750 rpm. The experimental temperature was 
25C.  The data were baseline corrected and integrated with NITPIC, fitted with a 
nonlinear least squares routine using a single-site binding model94.  
 
2.11 NMR spectroscopy 
 
2.12 Solution-state NMR spectroscopy 
 
Solution NMR data were recorded on a 700 MHz Avance II (Bruker) spectrometer 
equipped with a cryogenically cooled probehead. Data acquisition and processing was 
done using TopSpin 3.5 (Bruker Biospin). Further data analysis and resonance 
assignments were performed using the software Cara95. All the samples were locked 
against the deuterium signal (10% (v/v) D2O) and contained 1 mM 4,4-dimethyl-4-
silapentane-1-sulfonic acid (DSS) for internal referencing. All solution-state NMR 




1D proton spectra were acquired using WATERGATE11 for water suppression. Spectra 
were acquired using 16k complex data points and 64 co-added scans. The data were zero-
filled to 32k and processed using a squared sine window function. 
 
Backbone Resonance Assignment of apo-Bamb_5919 ACP 
 
U-13C-,15N-labelled Bamb_5919 ACP was dissolved in 500 μL of NMR buffer (Table 2.3) to 
obtain a protein concentration of ~700 μM and pippeted into 3 mm NMR tubes 
(Wilmad, Sigma Aldrich). Table 2.5 summarizes the NMR experiments and relevant 
acquisition parameters. 
 
Table. 2.5 NMR experiments performed for apo-[U-13C,15N] Bamb_5919_ACP 
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Experiments FID NS Spectral width (ppm) Miscellaneous 
1H-15N HMQC96 2048x128 16 35 (15N)  
HNCO97 1114x64x120 16 35 (15N)  x 20 (13C)  
CBCA(CO)NH98 2048x56x116 48 35 (15N) x 80 (13C)  
HNCA99–102 2018x48x96 16 35(15N) x 30(13C)  





2048x56x200 16 80(15N) x 80(13C)  
NOESY-
HSQC101,105,106 
2048x48x160 16 40(15N) x 16(13C) 100 ms mixing time 
 
Solution-state NMR titrations  
 
For protein-protein interaction studies, 15N-labelled Bamb_5919 ACP (long construct), 
Bamb_5919 ACP and Bamb_5917 PCP were dissolved to a concentration of 100 μM. 
Bamb_5919 KS0 (350-450 μM) was added at each titration step to obtain the 
concentrations of 9.79, 19.19, 28.21, 45.21, 64.70, 82.50, 98.81, 113.81, 127.64 and 
140.45 μM. A 2D 1H-15N SOFAST-HMQC96 spectrum was acquired at each titration point.  
The affinity (Kd) of each residue was calculated individually based on the decay in integral 







where P defines dissociation of the carrier protein from its complex with Bamb_5919 KS0 
at its single site (L). A stands for a multiplier constant that takes into account error in the 
integral of the first data point. The fitting was performed in Matlab R2107b by using the 
script provided by prof. J.R.Lewandowski. 
To define the likely interacting residues, the mean Ka value (Ka=
1
Kd
 ) was calculated for all 
the residues and those with a Ka value larger than the mean + 3σ were considered 
outliers. After no residues with Ka values larger than the average plus 3 s.d. were left, the 
mean was recalculated and the threshold defined as the mean + σ. Errors were 




15N relaxation measurements 
 
U-15N-labelled Bamb_5919_ACP was dissolved in 500 μL of NMR buffer (Table 2.3) to 
obtain a protein concentration of ~700 μM. 
The 15N longitudinal (T1) values were measured using pseudo-3D pulse sequence 
hsqct1etf3gpsi3d and delay times were set at 19.96, 33.92, 50.88, 67.84, 84.80, 101.76, 
135.68, 169.70, 203.52, 237.44, 305.28 and 339.92 ms. The 15N transversal (T2) values 
were measured using pseudo-3D pulse sequence hsqct2etf3gpsi3d, with 
the T2 relaxation delays corresponding to 0.035, 0.075, 0.125, 0.3, 0.4, 0.5, 0.8, 1.5, 2 and 
3 s. Other relevant experimental parameters are listed in Table 2.6. 
 
Table 2.6. Parameters used in NMR 15N dynamics measurements 
Experiments FID Number of scans Spectral width (ppm) 
15N R1 4096x128 16 14 (1H) x 38(15N) 
15N R2 4096x128 16 14 (1H) x 38(15N) 
15N–1H NOEs 4096x512 64 14 (1H) x 35(15N) 
 
Relaxation rates for each residue were derived from fitting curves with mono-exponential 
decays using Levenberg Marquardt algorithm in OriginPro 2018.  
The {1H}-15N heteronuclear NOE was measured by employing the pulse sequence 
hsqcnoef3gpsi, and the 15N-1H NOE values were obtained by the ratio of peak intensities 
with and without a proton saturation.  
 
2.13 Magic-angle-spinning (MAS) NMR spectroscopy 
 
Analysed protein complexes were prepared by mixing 100 µM U-15N-labelled Bamb_5919 
KS0 and 200 - 500 µM carrier protein in 500-700 µL NMR buffer volume (Table 2.3, 
pH=6.5). The samples containing gadolinium diethylenetriaminepentaacetic acid 
bismethylamide (Gd(DTPA-BMA)) were preparing by adding 0.2 mM Gd(DTPA-BMA).  
Samples were incubated for 30 min at room temperature and then centrifuged (12000 g, 
10 minutes, 4C) to remove impurities. The sedimentation followed at 300000 g - 700000 
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g  and 4C for 24-120 hours (Optima™ Max-XP Tabletop Ultracentrifuge and MLA-150 
Fixed-Angle rotor, Beckmann). Resulting supernatant was removed and used to dissolve 
15 mg of DSS. 50 µL was carefully pipetted back into the centrifugation tube to prevent 
dehydration of the sediment and to introduce DSS into the sample during rotor packing. 
Sediments were manually packed into 0.8 mm or 1.3 mm rotors by using dedicated 
packing tools. 
Solid-state NMR experiments were recorded at 500 MHz Bruker Avance III and 700 MHz 
Bruker Avance III HD spectrometers using a 1.3 mm Bruker probe in HCN configuration 
at 60 kHz MAS. 100 kHz MAS experiments were recorded at Bruker 600 MHz Bruker 
Avance II+ spectrometer using a 0.80 mm double-resonance probe from Samoson 
laboratory.  A Bruker BCU-X cooling unit was used to regulate the internal sample 
temperature to 28-35 °C (as indicated from the chemical shift of water with respect to 
DSS). The magic angle and the homogeneity of the magnetic field were optimized by using 
alanine. Topspin 3.5 was used to process NMR data.  
For the 1H-15N cross-polarization (CP) experiment carried out at 60 kHz, 90° pulses were 
set to 2.5 µs at 100 kHz nutation frequency for 1H and 3.0 µs at 83.3 kHz nutation 
frequency for 15N. At 100 kHz, the hard pulses were set to 2.0 µs at 125 kHz nutation 
frequency for 1H and 3.0 µs at 83.3 kHz nutation frequency for 15N. WALTZ-16 decoupling 
at 10 kHz was applied on protons during 15N evolution and on 15N channel during direct 
1H acquisition, while quadrature detection was achieved using the States-TPPI method. 
Suppression of the water signal was achieved by saturation 120 ms of MISSISSIPPI at an 




Chapter 3 - Interaction of acyl carrier protein and non-elongating 




As discussed in Chapter 1, a key step in enacyloxin biosynthesis is the transfer of 
polyketide chain from an ACP domain in module 10 to a standalone peptidyl carrier 
protein by a KS0 domain, which is necessary for the condensation domain to catalyse 
polyketide chain release via intermolecular esterification with DHCCA. Thus, the KS0 
transfers the substrate from a carrier protein (ACP), which is unable to interact with the 
C domain, to the carrier protein that can establish the interaction (PCP).  
The aim of this chapter was to analyse the interaction interface between ACP and KS0 as 
the first step towards the characterisation of the overall ACP-KS0-PCP interface, i.e 
understanding what structural aspects make PCP a favourable interaction partner with C 
domain compared to ACP. This comparison is presented in Chapter 5. 
Firstly, the NMR backbone assignment of apo-ACP was required to provide a ‘map’ of the 
protein which allowed the effects of KS0 binding on ACP to be investigated directly.  
Previously, the ACP protein domain construct was created by Dr. P. Sydor in the Challis 
lab. The construct comprised a sequence beginning at residue 1614 and ending at residue 
1800 of the original endogenous protein domain (Supplementary Figure S.1). This 
construct was used in the work mentioned in Chapter 1 (section 1.5), where it was shown 
that ACP does not establish contact with C domain87. However, to facilitate solution-state 
NMR structural analysis, a shorter construct was created by Dr. S. Kosol (beginning at 
1626 and ending at 1769 of the native domain) with truncated unstructured tails which 
were supposed not to hinder the interaction with KS0 (Supplementary Figure S.1). The 
construct created by Dr. Sydor is referred to in the text as ‘long Bamb_5919 ACP’ and the 
construct created by Dr. Kosol as ‘short Bamb_5917 PCP. The KS0 construct, termed 




The homology model of short apo-Bamb_5919 ACP created by Phyre2 109 server revealed 





Figure 3.1 Homology model of apo-Bamb_5919 ACP (A). Position of conserved serine 
residue is indicated. 98 residues ( 68% sequence coverage) have been modelled with 
99.9% confidence by the single highest scoring template. 
Multiple sequence alignment of ACPs with the known PDB structure from different 
systems (B). ACP19 – short Bamb_5919 ACP sequence. PDB identifiers: 2KR5 - Aspergillus 
parasiticus, 2AF8 - Streptomyces coelicolor, 2PNG - Rattus norvegicus, 1KLP - 
Mycobacterium tuberculosis, 2DNW - Homo sapiens, 2FVE - Spinacia oleracea, 2FQ0 - 
Plasmodium falciparum, 1HY8 - Bacillus subtilis, 2N57 - Brucella melitensis, 4IHF - 
Escherichia coli. 
The alignment of the long and short Bamb_5919 ACP construct reveals that the long 
construct contains longer terminal tails(C). The regions predicted as helical are 
highlighted. The alignments were done in Clustal110. 
 
3.2 Biophysical and biochemical characterization of Bamb_5919 ACP and 
Bamb_5919 KS0 
 
3.2.1 Protein expression and purification 
 
All constructs were expressed with N-terminal His affinity tag of 34 residues to facilitate 
protein purification. The tag sequence comprised the Tobacco Etch Virus protease (TEV) 
cleavage site EXXYXQ-S/G (TEVp cleavage Site, TS) where X can be any amino acid111. The 
cleaved proteins also contained residues GIDPFT belonging to His-tag. Bamb_5919 ACP 
and Bamb_5917 constructs that were used for NMR studies always had the His-tag 
removed. The expected masses of protein constructs are listed in Supplementary Fig. S.2. 
The purification of Bamb_5919 PCP is described in this section since it was used for the 
bioactivity assay described in this section. As described in Chapter 2, the supernatant 
resulting from cell-free extracts was firstly purified on a Ni+ affinity column (Figure 3.2.C). 
The tag was then cleaved (Figure 3.2.A, D) and fractions further purified by size-exclusion 
chromatography to ensure high purity (Figure 3.2 B, D, E). 11 mg of purified Bamb_5919 
ACP was obtained from 1 L of LB and 8 mg was obtained from M9 E. Coli cultures (15N 
and 15N13C-labelled protein), as determined by dry weight (after liophylisation) of the 
purified protein pellet. The same yields were obtained for the long construct. Contrary to 
the long construct, short Bamb_5919_ACP did not retain any tyrosines or tryptophans in 
its protein sequence after His-tag removal so it was not possible to use A280 absorption 
as a reliable protein concentration measurement reference. Bradford assay was 
attempted, but the obtained measurements were not consistent, probably due to the 
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quality of the reagent and pipetting errors. The concentrations of proteins with high 
enough extinction coefficients (Bamb_5919 KS0 and Bamb_5917 PCP) that were 
calculated based on A280 absorption were the same as those calculated from the dry 
weight of the proteins. For that reason, this method was used to estimate the mass and 
concentration of Bamb_5919 ACP. Bamb_5919 ACP appeared to be stable following 
sequential freeze-thawing at room temperature for 30 days as seen by the lack of 
precipitation and subsequently recorded 1H-15N-HMQC spectra.  
The Bamb_5919 KS0 domain was also expressed with an N-terminal tag for facilitated 
purification on Ni+ affinity column. To ensure higher purity, it was further run through 
the size exclusion column (Figure 3.2.E). The tag was not cleaved as the total contribution 
of 34 His-tag amino acids was not supposed to significantly interfere with the overall 
protein (670 amino acids) behaviour. The total yield was 30 mg from 1L of LB medium. 
To avoid precipitation, protein stocks were kept at the concentration of 50 M and 
concentrated to a maximum of 350 M if needed, usually for NMR titration experiments. 
Bamb_5917 PCP was purified using Na2+-affinity and gel-exclusion chromatography 
(Figure 4.2.), after His-tag removal. Approximately 13 mg of protein was obtained from 1 
L of LB culture and 11 mg from M9 culture. Freeze-dried Bamb_5917 PCP appeared to be 
stable following sequential freeze-thawing and was not subject to proteolysis.  





Figure 3.2 12% SDS-PAGE gels showing the purification and His-tag cleavage of the 
proteins used in the project. A) His-tag cleavage of short Bamb_5919 ACP. B) The samples 
taken from each eluted fraction after the size-exclusion purification of short-Bamb_5919 
ACP with a removed His-tag. C) Long Bamb_5919 ACP fractions after Ni2+ affinity 
purification. D) The samples of Bamb_5917 PCP taken after gel-exclusion 
chromatography. The gel also shows the cleavage of a His-tag. E) Bamb_5919 KS0 purified 
after size-exclusion chromatography.  
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3.2.2 Analysing thermal stability of Bamb_5919 ACP and Bamb_5119 KS0 by circular 
dichroism 
 
As NMR analysis was the main experimental tool used in the project, it was important to 
understand the effect of temperature on the integrity of the samples, i.e. secondary 
structure and fold. NMR experiments are usually run for several days so it was 
important to ensure that the samples would not degrade or have their secondary 
structure altered if exposed to the targeted experimental temperature. 
Circular dichroism (CD) is an excellent technique for rapid characterisation of the 
secondary structure and folding properties of purified proteins and is used to determine 
whether the purified protein is folded. CD can also be used to monitor conformational 
changes due to temperature112. However, CD does not give the residue-specific 
information that can be obtained by X-ray crystallography or NMR, but provides a more 
robust way to assess temperature effects on protein fold.  
Protein secondary structure can be determined by CD in the spectral region between 190 
nm and 250 nm, which is within UV region of the electromagnetic spectrum. The main 
chromophore in this region is the amide linkage of peptide bond113. -Helix, β-sheet, and 
random coil structures give rise to a characteristic shape of CD spectrum.  However, CD 
spectra provide the global picture of the protein secondary structure and it is not possible 
to determine the position of a backbone amino acid within a protein. Therefore, the CD 
spectra are generally used to assess the effect of different experimental conditions on 
proteins. 
CD analysis of apo-Bamb_5919 ACP (Figure 3.3A) revealed that an increase in 
temperature from 20 °C to 50 °C did not significantly affect its fold. Apo-Bamb_5919 
ACP seems to be mostly helical (~40%) at 20 °C to 40 °C (Figure 3.1A). It was not 
possible to determine the melting temperature from the melting curve (Figure 3.1B). 
The CD analysis of Bamb_5919 ACP was performed on apo protein, but the addition of 
Ppant arm should not significantly affect the protein fold. It thus was assumed that 
secondary structure characteristics of holo Bamb_5919 ACP should be similar to apo-





Figure 3.3 CD analysis of apo-Bamb_5919 ACP. A) CD spectra recorded at a temperature 
range between 20 °C and 90°C. Secondary structure analysis (Dichroweb) at 20°C and 
40°C is indicated. B) Melting curves at 222 nm, 206 nm and 191 nm. 
 
On the other hand, the secondary structure of Bamb_5919 KS0 seems to be more 
susceptible to changes when temperature increases to 40 °C, compared  to Bamb_5919 
ACP. CD spectra recorded at 40°C (Figure 3.4A) showed that the secondary structure 
profile is significantly different compared to its profile at 20°C. The melting temperature 
estimated from the melting curve at 206 nm was between 50 and 60°C. 
 
 
Figure 3.4 CD analysis of apo-Bamb_5919 KS0. A) CD spectra recorded at a temperature 
range between 20 °C and 90°C. Secondary structure analysis (Dichroweb) at 20°C and 40°C 




Thus, CD indicated that increasing the temperature during NMR measurement above 
30°C might affect the fold of Bamb_5919 KS0 and potentially its function. 
 
3.2.3 Characterisation of long and short Bamb_5919 ACP  
 
It has been mentioned in the introduction of this Chapter that the short Bamb_5919 ACP 
construct was created to facilitate NMR analysis. However, it was important to ensure 
that this constructs retained its bioactivity after the terminal parts of the long 
Bamb_5919 ACP had been removed. For that purpose, solution-state NMR titrations 
were used.  It was initially planned to titrate both long and short 15N-Bamb_5919 ACP 
with Bamb_5919 KS0 and monitor whether the excised parts of the tails might be involved 
in the interaction. The relevant information related to the analysis of protein-protein 
interactions by solution-state NMR titrations is provided later in the Chapter. 
Firstly, to inspect whether the constructs were properly folded, 15N-HMQC spectra were 
taken. The theoretical details about HMQC and HSQC spectra is provided later in the 
chapter. Compared to short Bamb_5919, long Bamb_5919 ACP produced a greater 
number of overlapped signals clustered in the central region of the spectrum (1H: 8 – 8.5 
ppm) (Figure 3.5). This was due to the presence of long unstructured terminal parts of 
long Bamb_5919 ACP. Generally, the residues located in that region are likely to be 
disordered. Unfortunately, due to that signal overlap, it was not possible to extract 
intensities of the individual peaks located in the central part of the spectrum and 






Figure 3.5 1H-15N-HMQCs of the long and short apo-Bamb_5919 ACP construct. The 
spectra were recorded at 700 MHz and 298 K in the buffer containing 50 mM sodium 
phosphate, 50 mM NaCl and 10 % D2O. 
3.2.4 Bioactivity assay 
 
The NMR analysis of the long and short Bamb_5919 ACP discussed in the previous 
chapter did not provide enough information to determine whether the short Bamb_5919 
ACP is functional. Hence, to confirm its bioactivity and to demonstrate that the truncated 
disordered tails are not essential for function, the transfer of a substrate from holo-
Bamb_5919 ACP to holo-Bamb_5917 PCP was reconstituted in vitro in the presence and 
absence of Bamb_5919 KS0. The bioactivity of the His-tagged long Bamb_5919 ACP had 
already been confirmed by dr. P. Sydor87 by the same assay. This reaction was thus used 
as a positive control. Also, all analysed domains contained His-tag. Firstly, carrier proteins 
were converted from apo to holo forms. The LC-MS spectra recorded for apo and holo 
proteins, together with expected masses are listed in Supplementary Figure S.2. An acetyl 
group was used as a natural substrate mimic, which was not feasible for chemical 
synthesis. 
Generally, the length of the bound substrate chain does influence the dynamics of 
ACPs114. For example, the study of the effect of fatty acid chain length on the dynamics 
of the spinach fatty ACPs showed that longer attached fatty acids result in faster 
hydrolysis. However, the differences in the rate of hydrolysis for the smaller fatty acids 
were generally small. Interestingly, however, pentadecanoic (15:0) fatty acid is the 
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longest fatty acid that can be easily accommodated within the spinach ACP binding 
pocket as longer fatty acids lead destabilization of the protein fold 74. This suggests that 
using a short acyl chain as a substrate mimic should not significantly alter the dynamics 
and the properties of Bamb_5919 ACP compared to its natural substrate. 
The transfer of the acetyl group from long holo-Bamb_5919 ACP to holo-Bamb_5917 PCP 
was monitored by detecting both acetylated and deacetylated species of carrier proteins 
(Figures 3.6 and 3.7). In the presence of Bamb_5919 KS0, the acetyl group was transferred 
from long holo-Bamb_5919 ACP to holo-Bamb_5917 PCP, which can be seen as two 
peaks representing both acetylated and deacetylated long Bamb_5919 ACP and 
Bamb_5917 PCP, since the acetylation and deacetylation reactions are expected to be in 
equilibrium (Figure 3.6A). In a negative control experiment, where Bamb_5919 KS0 was 
omitted from the reaction mixture, the transfer of the acetyl group was not observed and 
only long acetyl-holo-Bamb_5919 ACP and holo-Bamb_5917 PCP were detected (Figure 
3.6 B). In addition to confirming the result obtained by Dr. Sydor, this also ensured that 
Bamb_5919 KS0 and Bamb_5917 PCP are functional. 
The same acetyl transfer reaction was monitored for short Bamb_5919 ACP. Both 
acetylated and deacetylated forms of holo-Bamb_5919 ACP and holo-Bamb_5919 PCP 
were observed, which confirmed that the truncated Bamb_5919 ACP retained its 
bioactivity (Figure 3.7). 
Thus, the short Bamb_5919 ACP was used for all the following experiments and is 






Figure 3.6 LC-MS analysis of the bioactivity assay for long Bamb_5919 ACP. The shown 
deconvoluted LC-MS mass spectra represent long holo-Bamb_5919 ACP and Bamb_5919 
PCP in presence (A) and absence of KS0 B). The expected masses of the used proteins are 
listed in Supplementary Figure S.2. Conversion from apo to holo form results in the mass 
gain of 358 Da, as a result of addition of phosphopantetheine. The reaction buffer was 




    
 
Figure 3.7 LC-MS analysis of the bioactivity assay for long Bamb_5919 ACP. The shown 
deconvoluted LC-MS mass spectra represent short holo-Bamb_5919 ACP and Bamb_5919 
PCP in presence (A) and absence of KS0 B). 
 
3.2.5 Kinetic profile of Bamb_5919 ACP:Bamb_5917 KS0 interaction  
 
The kinetics of the interaction between Bamb_5919 ACP and Bamb_5919 KS0 was 
investigated using bilayer interferometry (BLI) and isothermal calorimetry (ITC).   
Like SPR and ITC, BLI is a label-free optical analytical technique for measuring 
biomolecular interactions. It analyses the interference pattern of white light reflected 
from two surfaces: a layer of immobilized protein on the biosensor tip and an internal 
reference layer115–117. Any change in the number of molecules bound to the biosensor tip 
causes a shift in the interference pattern that can be measured in real-time. BLI provides 
the ability to monitor the kinetics of a molecular reaction by monitoring rates of 
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association and dissociation (kon and koff rates, respectively) using simple dip and read 
assays. From these rates, the overall reaction affinity (Kd) can be calculated.   
















where A and B are the ligand and analyte concentrations and ka/kd are the on- and off-
rates. Kd is represented in molar units (M). The Kd is the concentration of the protein 
which occupies half of the binding sites of the binding partner at equilibrium.  
Therefore, a lower Kd value is characteristic of stronger protein-protein interactions since 
less free protein is required to occupy 50% of the binding sites. Reversely, a high Kd value 
implies a weak binding. Ka is the reciprocal of Kd and measures the affinity of the ligand 
for the target. A ligand with a high Kd value has a low Ka value and therefore low affinity 
for the target. 
In biosensor analysis, one interacting partner is immobilized on the surface of the 
biosensor (ligand) and the other remains in solution (analyte). The assay begins with a 
baseline or equilibration step using assay buffer (Figure 1.8). Next, a ligand molecule is 
immobilized on the surface of the biosensor (loading). Biosensors are dipped into the 
buffer solution for a baseline step after ligand immobilisation and to assess the ligand’s 
load level. Next, in the association step, biosensors are dipped into a solution containing 
the binding partner (the analyte, where the binding of the analyte to the ligand being 
immobilised on the sensor surface is quantified. In the final step, the biosensor is dipped 
into a buffer solution which does not contain an analyte so the bound analyte can 





Figure 3.8 Schematic representation of a binding kinetics experiment on streptavidin 
biosensors. The sensorgram shows loading, baseline, association, and dissociation assay 
steps. 
 
Having a precise Kd value for Bamb_5919 ACP:Bamb_5919 KS0 binding was important to 
complement solution-state NMR titration analysis, which is discussed later in the chapter. 
The buffer conditions selected for the affinity measurements were thus the same as 
those selected for NMR titrations. Apo and holo-Bamb_5919 ACP were bound to the 
sensors and titrated with increasing concentrations of Bamb_5919 KS0. The binding was 
evident from the increase in signal at higher concentrations of Bamb_5919 KS0 
(Supplementary Figure S.3). Fitting of the data to a direct binding isotherm revealed a Kd 
of 2.43  0.48 µM (an average value of the triplicate measurements) for the binding of 
apo-Bamb_5919 ACP and 0.16 µM  0.02 µM for the binding of holo-Bamb_5919 ACP 
(Figure 3.9), indicating that holo form of the protein binds stronger to the ligand 
compared to apo form. This was consistent with a study of type 1 mycolactone PKS, 





Figure 3.9 BLI steady-state analysis profile for of a Bamb_5919 ACP-Bamb_5919 KS0 
interface. The steady-state analysis determines the affinity constant Kd from the measures 
equilibrium response.  A The binding of apo- Bamb_5919 ACP with Bamb_5919 KS0. B) 
The binding of holo-Bamb_5919 ACP to Bamb_5919 KS0. The raw binding data and fitting 
curves are shown in Supplementary S.3. The data presented in the Figure is an average of 
the triplicate measurements. Errors resulted from the differences between observed 
responses in each dataset. 
 
However, the fitting of the real-time sensorgram curves showed the characteristics that 
deviated from the classical 1:1 bimolecular interaction. The best fit was achieved with 2:1 
fitting, which indicated complex, non-ideal binding. Ideally, assay conditions should be 
optimized until the profile displays 1:1 binding characteristics. A complex, non-ideal 
binding profile in a kinetic assay can be caused by several  factors, such as non-specific 
binding to the biosensor, when analyte concentrations are far above the Kd or when the 
ligand density on the surface is high. However, lowering the analyte concentration range 
in this assay, as well as lowering the ligand density on the surface, did not significantly 
shift the fitting to 1:1 binding scenario. Thus, the non-ideal binding was probably the 
result of the structural heterogeneity of the ligand or analyte, occurring either in the 
original sample or as a result of artefacts in the assay, or the presence of partially active 
or inactive proteins.  
 
BLI provided Kd values of the interactions, but to get information about changes in 
enthalpy of the binding, ITC was performed. ITC works by directly measuring the heat 
that is either released or absorbed during a biomolecular binding event. ITC is the only 
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technique that can simultaneously determine Kd, enthalpy and entropy of binding in a 
single experiment. 
Enthalpy and entropy of binding, together with Gibbs energy, form the basic 
thermodynamic binding profile for a specific interaction. Gibbs energy is calculated from 
Ka: 
 
∆𝐺 = −𝑅𝑇𝑙𝑛𝐾𝑎 = 𝑅𝑇𝑙𝑛𝐾𝑑, 
 
Where T stands for absolute/thermodynamic temperature and R for gas constant. 
Furthermore, Gibbs energy can be partitioned into its enthalpic, ΔH, and entropic, TΔS, 
contributions: 
∆𝐺 = ∆𝐻 − 𝑇∆𝑆. 
 
Combination of these three thermodynamic parameters offers basic and valuable 
information on the binding process. For example, endothermic profile suggests that 
protein-protein interactions are mediated by hydrophobic residues whilst exothermic 
reaction indicates polar interactions114.  
As well as for BLI, no tagging or modifications of binding partners are required. However, 
contrary to BLI, it does not require protein immobilization so ITC measures the affinity of 
binding in the native states of binding partners. However, the disadvantages of ITC 
include a large amount of required sample and the hardly detectable small binding 
enthalpies exhibited by non-covalent complexes, such as the complex formed by carrier 
proteins and ketosynthases. 
During ITC measurement, a biomolecule solution is initially placed in the sample cell 
during the measurement and a ligand solution is placed in the syringe in a corresponding 
buffer. When the ligand solution is injected into the cell and the interaction occurs, the 
ITC instrument detects the released or absorbed by measuring the changes in the power 
required to maintain the same temperature between the reference and the sample cell 
(DP). Injections are performed repeatedly and result in peaks that become smaller as the 
biomolecule becomes saturated. Eventually, the peak sizes remain constant and 
represent only the heats of dilution114.  
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The binding of apo and holo-Bamb-5919 ACP and Bamb_5919 KS0 was evident from the 
decrease in DP (Figure 1.10). A single measurement of the interaction recorded for apo-
Bamb_5919 ACP indicated that the binding is weaker compared to holo-Bamb_5919 ACP, 
which was consistent with the BLI results. However, the attempts to replicate the 
measurements failed due to the presence of bubbles in the samples that affected the 
measurements, even after degassing. This indicated that the sample solutions were 
highly viscous, which complicated the removal of the bubbles. Also, the offset (signal 
obtained from the reference analyte buffer to water titrations) was substantial and some 
of the replicated measurements could not yield distinguishable signal originating from 
the very binding reaction. This background signal probably emerged from the buffer 
impurities, which can affect the measurements since the signal originating from the 
mixing of these impurities with water can generate heat which can be greater than the 
heat released or absorbed by the protein interaction. Furthermore, the stoichiometry 
obtained from the measurements was far off 1:1 binding scenario. This indicated that 
actual concentrations of the proteins were not correctly estimated, probably due to 







Figure 3.10 ITC analysis of the binding between Bamb_5919 ACP and Bamb_KS0. The 
measurement obtained for apo-Bamb_5919 ACP (upper and lower left figure). B) The 
results obtained for two replicates of apo-Bamb_5919 ACP measurements (upper and 
lower right figure). The dilution control has been subtracted from titration. 
 
3.3 NMR spectroscopy for the study of proteins 
 
To understand the NMR experiments used to analyse the protein interactions, the 
important concepts related to NMR spectroscopy, will be described first114. 
NMR is a powerful tool for studying the structures of macromolecules and more than 
12,500 NMR structures of proteins have been deposited in the PDB to date. The 
development of Fourier transform NMR and multidimensional NMR methods allowed for 
faster experiments and correlation of resonances between spatially proximal or bound 
nuclei, which improved the applicability of NMR to study proteins. NMR can be used to 
produce structures of proteins up to ~30 kDa using the standard methods that will be 
described in this chapter. Advances in molecular biology methods have enabled isotopic 
enrichment of 13C and 15N nuclei that are relevant for NMR. Overexpression of proteins 
in E. coli has made sequential backbone assignment of backbone 13C, 13CCO, 1H and 15N 
atoms possible. NMR pulse sequences, such as TROSY114,119, together with developments 
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in data processing have allowed for even larger proteins to be studied (50-1000 kDa). 
Proteins of that size are otherwise not accessible to high-resolution solution-state 
NMR120. The assignment of the protein backbone resonances can also help in the 
resonance assignment of the side-chain atoms directly bound to the backbone residues 
and thus enable the characterisation of the dynamics and conformational states of both 
the protein backbone and sidechain121,122. Furthermore, the development of high field 
NMR spectrometers with
 1H Larmor frequencies of 900 MHz and above, together with 
cryogenically cooled probes, have significantly increased the sensitivity and resolution of 
NMR experiments. NMR can be used to study proteins in solution and so it offers a 
significant advantage over alternative techniques in maintaining natural protein 
dynamics and flexibility. NMR can also be used to map protein-protein interactions and 
report on the timescales of internal dynamics, conformational exchange and ligand 
binding. 
 
The NMR signal 
 
All nuclei which do not contain an even number of protons and neutrons possess the 
quantum mechanical property known as the spin angular momentum, commonly 
referred to as the ‘nuclear spin’, which is described using the nuclear spin quantum 
number, I. Spin is an intrinsic property of the nucleus, like mass and charge, and does not 
arise from its spinning. The nuclei with I = ½, such as 1H, 15N and 13C are the most useful 
for protein NMR because they split into only two energy levels that are parallel and 
antiparallel to the applied magnetic field. The ratio of parallel to antiparallel spins is given 
by a Boltzmann distribution which shows that the two energy levels are nearly equally 
populated at thermal equilibrium. As a result, NMR possesses low sensitivity. 1H is 
naturally abundant (99.99 %), whilst 13C (~1 % natural abundance) and 15N (~0.4 %) can 
be incorporated during protein expression to increase the abundance. The nuclear spin 
angular momentum of a nucleus with I ≠ 0 gives rise to a magnetic moment. The z-
component of the magnetic moment (µ) is the z-component of the angular momentum 





µ =  γÎz. 
 
The energy of the interaction depends upon the angle (θ) between the magnetic moment 
and the applied field. The energy is lowest when the applied field and magnetic moment 
are parallel (θ = 0) and highest when they are antiparallel (θ = π radians). Therefore, the 
alignment of the nuclear magnetic moment to the applied field is energetically favourable 
and the lower energy orientations become preferentially populated over time. The 
energetic preference is opposed by thermal motion so the net alignment that arises is 
very small. Nonetheless, even this small alignment is such that the sample acquires its 
magnetic moment, which is known as the bulk or equilibrium magnetisation. This 
alignment is in the same direction as the applied magnetic field, i.e. along the z-axis. The 
extent of the bulk magnetisation increases with the increase in the field strength. For 
protein NMR, magnetic fields of more than 500 MHz are required to achieve sufficient 
magnetisation. The equilibrium magnetisation does not change its direction or size over 
time. However, if this magnetic moment is perturbed away from the z-axis towards the 
xy-plane, the vector precesses about the z-axis (Figure 3.11). The frequency of precession 
depends upon the gyromagnetic ratio (γ) and the applied field (B0) and is known as the 
Larmor frequency (ω0): 
 
ω0 = -γB0. 
 
The NMR signal originates from the precession of the magnetisation vector, which is 
detected by a coil of wire placed around the sample along the x-axis (Figure 3.11). When 
the magnetisation vector crosses the coil, the current is induced and recorded as the free 
induction decay (FID). The signal decays due to relaxation of the magnetisation vector 






Figure 3.11 Magnetisation and the NMR Signal. The equilibrium magnetisation that builds 
up after a few seconds in a magnetic field is along the z-axis. The direction and magnitude 
of the equilibrium magnetisation vector do not change over time. Following perturbation 
of the magnetisation vector away from the z-axis into the xy-plane, the vector precesses 
about the z-axis at the Larmor frequency (ω0 = -γB0) for a nucleus with a positive 
gyromagnetic ratio such as a proton. As the vector crosses the receiver coil placed around 
the x-axis, an electrical current is generated. The current is known as the free induction 
decay (FID) and represents an NMR signal. 
 
The precise magnetic field experienced by a nucleus depends on its chemical 
environment. Each nucleus within a protein effectively experiences a different B0. 
Therefore, the Larmor frequency of each nucleus is also different. This can be described 
mathematically by incorporating an additional term into the equation for the Larmor 
precession known as the chemical shift:  
ω0 =  −γ(𝐵0 − 𝐵𝑖), 
 
where B0 is the external magnetic field and Bi - induced magnetic field. 
 
The FID, which is converted to a spectrum of frequencies using the Fourier transform, 
contains the precession frequency of each spin active nucleus in the protein. These 
frequencies are given relative to the receiver reference frequency, which is typically 
placed by the user in the centre of the frequencies of interest. For example, to detect the 
peaks between 0 and 1000 Hz, the receiver would be placed at 500 Hz resulting in a 
spectrum going between -500 and +500 Hz. Further to this, the frequencies (v) are 
normalised relative to the frequency of a reference compound and quoted as chemical 









The final NMR spectrum contains a peak for each spin active nucleus in the protein at 
its Larmor frequency, given as a chemical shift in ppm. 
 
The NMR experiment 
 
The rotation of the equilibrium magnetization away from the z-axis and into the xy plane 
is fundamental to the NMR signal. Switching off the applied field (B0) along z and replacing 
it with a field along x or y is the most obvious means of achieving this, but it is simply not 
possible to switch the powerful superconducting magnets used to establish the bulk 
magnetisation off and on in this way. However, the applied field can be overcome by an 
additional small, oscillating magnetic field (B1) applied along the x-axis (or y-axis), known 
as the radio frequency (RF) field (or pulse). The B1 field is generated using the detector 
coil and is set to linearly oscillate at or close to the Larmor frequency. It can be considered 
as two counter-rotating fields (B1+ and B1), rotating at a frequency of ω1. The rotating 
field significantly interacts with the Larmor precession of a nucleus if it is rotating in the 
same direction but has no significant interaction if rotating in the opposite direction. This 
means that one of the two components can be ignored. For example, for a nucleus with 
a negative gyromagnetic ratio such as 15N, only the B1+ component of the RF field is 
rotating with the same sense as the Larmor frequency and so the B1- component can be 
ignored. Now, by observing B1+ from a rotating frame that rotates with the same sense 
and frequency as B1+, B1+ appears static. 
Observing the Larmor precession in this same rotating frame causes an apparent change 
to the Larmor frequency. The apparent Larmor frequency in the rotating frame is known 
as the offset (Ω) and is given by: 
 
Ω =  𝜔0 −  𝜔. 
 
The Larmor frequency is related to the applied magnetic field and so, in the same way, 




Ω =  −𝛾∆𝐵. 
 
This proportional relationship between the apparent field and the offset allows the 
apparent field to be reduced to zero simply by setting the frequency of the rotating frame 
(ωrotating frame) equal to the Larmor frequency (ω0). The rotating frame, therefore, gives us 
the power to apply an oscillating magnetic field along x or y that appears stationary as 
well as effectively converting B0 into a reduced field (ΔB) that is very small. The field now 
experienced by each spin is a vector sum of the apparent field (ΔB) and the RF field (B1) 
and is known as the effective field (Beff). When the frequency of the RF field is selected to 
match the Larmor frequency exactly, Ω = 0, ΔB = 0 and so Beff = B1. This is called an ‘on-
resonance’ pulse and it causes the magnetisation to rotate about the axis to which it was 
applied. The angle through which the magnetisation vector rotates (flip angle, β) depends 
on the frequency of the RF pulse and pulse length (tapp): 
 
𝛽 =  𝜔1𝑡𝑎𝑝𝑝. 
 
When the frequency of the RF field is very different from the Larmor frequency, Ω ≈ ω0 
and so Beff is dominated by ΔB. This is called an ‘off-resonance’ pulse and it essentially 
does not affect the magnetisation. The Larmor precession of 1H, 15N and 13C differ 
significantly due to their different gyromagnetic ratios and so a pulse that is on-resonance 
with protons will not affect the other nuclei. The basic ‘pulse-acquire’ NMR experiment 
consists of a 90° pulse on the x-axis, on resonance with the nucleus of interest, followed 
by signal acquisition (Figure 3.9). In terms of the ‘vector model’, the 90° pulse on x simply 
rotates the magnetisation vector from z onto -y and the magnetisation then precesses in 
the xy-plane during the acquisition of the FID. The addition of a 180° pulse before 
acquisition turns the pulse-acquire into the ‘spin-echo’. In the spin-echo, the equilibrium 
magnetization is rotated into the transverse plane as in the pulse-acquire and the spins 
precess within the xy-plane for time, τ. The spins do not precess at identical frequencies 
and so after τ, the magnetisation of each spin will have reached a different point along a 
circular path around z. When a 180° pulse is applied, all of the spins are rotated to be 
exactly opposite where they were before the pulse. The spins continue to precess at the 
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same frequency and in the same direction as before and so after another period of exactly 




Figure 3.12 The spin echo and pulse-acquire. The RF line contains the information on the 
RF pulses and the acquisition (AQ) line represents when the signal is recorded. The 
acquired FID is processed using the Fourier Transform to produce a spectrum with a peak 
for each spin active nucleus at its Larmor frequency, expressed as the chemical shift in 
ppm. The vector model diagram illustrates the changes to the bulk magnetisation that 








A good quality heteronuclear single quantum coherence experiment (HSQC) is a 
prerequisite for successful protein assignment. The spectrum comprises a set of peaks 
representing every NH group in the protein (Figure 3.13). 
 
 
Figure 3.13 Simplified and schematic representation of a 2D experiment. 2D experiments 
can be created by combining two 1D 1H and 15N spectra. Peaks in the 2D spectrum emerge 
only if there is a correlation between peaks in the 1D spectra. This can happen through a 
direct bond or through space. 
 
 This includes the backbone NH group of every residue (absent in prolines), the sidechain 
NH of tryptophan, histidine and arginine, the sidechain NH2 of arginine, glutamine and 
asparagine and the sidechain NH3+ of lysine. For arginine, however, the NH and NH2 
groups are often very weak due to exchange broadening and so may not be observed. 
The NH of histidine and the NH3+ groups of lysine are also not observed. The NH2 groups 
of glutamine and asparagine, however, give stronger peaks in the top right-hand region 
of the HSQC (δN = 110-115 ppm and δH =6.5-8.0). Two peaks are observed with equivalent 
nitrogen shifts, representing each proton attached to single nitrogen. The N-terminus is 
usually not visible due to exchange broadening. The 1H and 15N chemical shifts of each 
peak are determined by the chemical environment of the amide group, therefore the 
HSQC spectrum depends upon the fold of the protein. For this reason, the HSQC 
spectrum is often referred to as the protein’s fingerprint and a well-dispersed spectrum 
69 
 
is characteristic of a well-folded protein. The version of an HSQC experiment that was 
used in the work presented in the thesis is called HMQC.  
Also, 2D NOESY and TOCSY can be used to report on the secondary structure of a protein. 
The resolution of the peaks in the HN-Hα region of the TOCSY can indicate whether the 
protein can be studied by NMR. If the peaks in this region are very broad it could indicate 
oligomerisation or aggregation of the protein,that the protein is too large for classical 
NMR studies and that further NMR experiments will not provide the necessary resolution 
for structural studies. Good resolution in this region indicates that the much higher 
resolution double and triple resonance (1H/15N or 1H/15N/13C) experiments will be of 
ample resolution for backbone and sidechain assignments and structural studies. 
The INEPT123 is an important building block for many NMR experiments, including the 
HSQC. In its simplest form, this contains two INEPT sequences separated by an evolution 
time, t1 (Figure 1.10). During t1, the proton chemical shift is refocused by a 180° pulse but 
the 15N chemical shift is allowed to evolve.  
 
 
Figure 3.14 INEPT pulse sequence. The evolution of the magnetisation during pulses and 
periods of free precession. The red arrow indicates the transfer of magnetisation from the 
proton to 15N. This is necessary to encode the 15N shifts in the final signal.  Thus, the 15N 
chemical shifts are encoded and the magnetisation has been transferred back to the 
proton.  
 
The final signal encodes the 15N chemical shifts modulated by t1 and is detected on the 
proton channel. The resulting 15N-HSQC spectrum contains a signal for every NH group in 
the protein. Further extensions to the HSQC include the triple resonance experiments 
used for protein backbone assignments, in which the magnetisation is selectively 




Multi-dimensional NMR experiments that correlate the resonance frequency of the 
backbone nuclei of one amino acid residue (i residue) with that of the preceding (i-1) or 
the succeeding (i+1) residue are typically used for the sequential assignment of the protein 
backbone and sidechain nuclei (12Cα, 12Cβ, 13CO, 1H, and 15N).  
For example, the 3-dimensional HNCA experiment provides a correlation between the 1H 
and 15N nuclei of the backbone amide group with the 13Cα chemical shifts of the i residue 
and the i-1 residue. The connectivity information can be used in a chain process (linking 
the i-1 residue with the i residue and the i residue with the succeeding i+1 residue etc.) to 
complete assignment of the backbone 15N, 1H, and 13Cα nuclei. To distinguish possible 
ambiguities on which resonances originate from the i and i-1 residue, HN(CO)CA 
experiment can be performed, which only shows the correlation of the backbone 1H and 
15N with the i-1 13Cα nuclei and not the 13Cα resonance. Other experiments, such as the 
CBCA(CO)NH and the HNCACB experiments (which provide similar correlation 
information as the HN(CO)CA and the HNCA experiments with the addition of 13Cβ 
resonances) or the HNCO experiment (which provide correlation of the backbone 1H and 
15N resonances with the 13CO resonance) can aid in the assignment of the protein 
backbone nuclei. The assignment of additional sidechain nuclei can be performed using 
the hCCH-TOCSY experiment that shows the correlation of resonances of the sidechain 
13C atoms to the backbone nuclei (13Cα and 1Hα).  
The NMR resonance assignments for backbone and sidechain atoms can be used for the 
study of both structural as well as dynamics of the protein. Chemical shifts reflect the 
overall chemical environment of the nuclei and changes in the backbone 1H, 13C, and 15N 
chemical shifts can reflect changes in the protein conformation, presence of bound 





3.3.1 2D NMR analysis of apo-Bamb_5919_ACP 
 
The 1H-15N HMQC spectrum recorded for apo-Bamb_5919_ACP was well dispersed 
(Figure 3.15A.), indicating a well-folded protein. The 1H–15N HSQC of the Bamb_5919 ACP 
domain was therefore expected to contain a total of 142 backbone NH peaks. The initial 
number of the picked peaks was smaller than expected. However, without 3D 
experiments, it was not possible to distinguish overlapped peaks. Also, 2D 1H–1H NOESY 
(with 15N decoupling) was recorded on apo-Bamb_5919 ACP. In NOESY, there were many 
HN-HN cross-peaks in the amide region, arising from through-space NOE transfer of 
magnetisation between adjacent NH groups (Figure 3.15B). The abundance of cross-
peaks in this region indicated the expected well-folded structure. Together, these spectra 
indicated that Bamb_5919 ACP domain is most likely assignable. Hence, 15N and 13C 
labelled protein was expressed and purified for use in the triple resonance experiments 
required for backbone and sidechain assignment. The LC-MS spectra of the labelled 




Figure 3.15 2D NMR analysis of apo-Bamb_5919 ACP. 1H-15N HMQC (A) and 1H-1H 




3.3.2 Backbone assignment of apo-Bamb_5919 ACP 
 
To study conformational and dynamic changes in the Bamb_5919 ACP of upon 
interaction with Bamb_5919 KS0, an assignment of the protein backbone residues was 
required. Due to the size of the Bamb_5919 ACP (~ 15 kDa), 3D heteronuclear triple 
resonance experiments, were used to sequentially assign the protein backbone. Such an 
assignment relies upon a series of through bond experiments to be analysed with 
reference to the HSQCs. The amide chemical shift of each residue is encoded in the 15N-
HSQC. 15N-HSQC is the reference point during the assignment process. The navigation 




Figure 3.16 Representation of a 3D experiment. An HSQC peak is extended into a 3D 
carbon dimension to form a 3D dataset. Such a dataset can be analysed by using strip 
plots. Strip plots represent a 13C dimension at a 1H-15N position. This way, it is possible to 





This section will give a brief introduction to the NMR experiments used for the amino acid 
assignment and the sequential assignment method. 
The backbone assignment was performed using serial triple resonance experiments: 
HNCO, HNCA, HNCACB and HN(CO)CACB. These experiments depend upon the transfer 
of magnetisation via scalar couplings between the amide proton, amide nitrogen and 
carbon atoms. The magnetisation transfer pathways for each experiment are illustrated 
in Figure 3.17. 
 
 
Figure 3.17 Magnetisation transfer pathways in triple resonance NMR experiments. The 
diagrams illustrate the transfer of magnetisation via one or two bond J couplings, 
indicated by double-headed arrows. In each case, the magnetisation begins and ends on 
the amide proton. The chemical shift is allowed to evolve on all of the nuclei highlighted 
in blue and, as such, the chemical shift of each is encoded. The nucleus highlighted in 
green are utilised for magnetisation transfer in order to restrict the transfer pathway to 
the i-1 residue but their shifts are refocused and so not encoded. 
 
The HNCA contains a cross-peak resulting from the one-bond scalar coupling (1JNCα) 
between the NH and Cα and as such encodes the chemical shift of the NH and Cα for each 
residue. The HNCACB contains two cross-peaks for each NH group, one to the Cα and one 
to the Cβ. These experiments are therefore used to assign the Cα and Cβ corresponding to 
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each NH group. In some cases, the HNCA and HNCACB contain additional weaker peaks 
due to correlation of the NH to the Cα or Cβ of the preceding residue via the 2JNCα 
coupling. First, the NH strip for a residue (i) can be located in the HNCA by navigation 
from the HSQC. The Cα of the preceding residue (i-1) is visible in the HN(CO)CACB so can 
be used to locate the Cα in the HNCA of i-1 by matching the chemical shift. The 
corresponding peak is then located in the HSQC and linked sequentially to the starting 
HSQC peak. The i+1 strip can also be located using the Cα in the HNCA of residue i to find 
the corresponding Cα peak in the HN(CO)CA of residue i+1. In this way, it is possible to step 
along the protein backbone. 
 Sequence-specific assignments were made with the sequential linkages by comparison 
of the Cα and Cβ chemical shifts with reference values. More than 7 million chemical shift 
values from NMR assignments are contained within an online database, the 
BioMagResBank118. These values have been used to calculate the minimum, maximum 
and average value for the chemical shift of each 1H, 15N and 13C atom in specific amino 
acid types for apo-Bamb_5919 ACP and this information has been tabulated 
(Supplementary). The Cα and Cβ chemical shifts for each residue were compared with the 
reference values for different residue types and so the possible identities of each residue 
were deduced. The different amino acid types have overlapping chemical shift profiles so 
a single Cα/Cβ pair could not be assigned in isolation but, by matching the possible 
identities for stretches of sequentially linked residues with the amino acid sequence of 
apo-Bamb_5919 ACP, some sequence-specific assignments could be made. To overcome 
the limitations caused by Cα and Cβ chemical shift degeneracy between amino acid types, 
two further experiments were used in addition to the triple resonance experiments: the 
15N-NOESY-HSQC and HCCH-TOCSY. The NOESY relies on through space NOE transfer, 
whilst the TOCSY transfer relies on through bond scalar couplings. In both cases, the 
protons are first excited and their chemical shifts recorded. For the NOESY, the 
magnetisation is then put back on the z axis before mixing. For the TOCSY, the 
magnetisation is transverse during the mixing step. It is during this mixing step that the 
magnetisation is transferred across all of the protons via either through space NOE 
transfer or through bond J couplings. 
Both experiments end with a 15N-HSQC and so the magnetisation is transferred back to 
amide protons via nitrogen before detection. As a result, only correlations between the 
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NH groups and other protons are recorded. The magnetisation transfer pathways for 
these two experiments are shown in Figure 3.18. 
 
 
Figure 3.18 Magnetisation transfer pathways in the 15N-NOESY-HSQC and HCCH-TOCSY. 
The nuclei for which the chemical shift is recorded are highlighted in blue.  
 
The NOESY mixing time is selected so that only direct side-chain proton to NH group NOEs 
are recorded. This is typically 100 msec for small proteins. If the mixing time is too short, 
only the NOEs between the closest protons will be detected and longer distance 
information will be lost. If it is too long, the NOEs will contain additional magnetisation 
transferred from other nearby protons and so will not provide an inaccurate measure of 
the distance between sidechain protons and the amide groups. This is called spin 
diffusion. The TOCSY mixing time must be long enough for the magnetisation to reach 
the more distant protons but if it is too long the signals will be lost due to relaxation. In 
the TOCSY, all of the cross-peaks are intra-residue as the magnetisation is transferred 
through scalar couplings and is not transferred via the N-CO or Cα-CO bonds and the 
protons that are connected via the fewest bonds to the NH group will give the strongest 
cross-peaks. In theory, the TOCSY provides the proton shifts across the complete 
sidechain, providing a useful fingerprint for amino acid type. However, for most residues 
of apo-Bamb_5919 ACP, the TOCSY transfer was only sufficient to identify the Hα. This is 
because the 3JHN-Hα coupling constant is small (4-6 Hz) in helical proteins and so 
magnetisation transfer from all but the Hα requires impracticably long mixing times that 
would result in the pronounced signal loss to relaxation.  
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Conversely, the NOESY experiment relies upon through space correlations that are 
efficient up to 5 Å and so for apo-Bamb_5919 ACP it did provide sidechain fingerprints. 
The NOESY contains intra- and inter-residue NOEs and the intra-residue NOEs are often 
strong as the intra-residue protons are close in space to the NH group. The inter-residue 
NOEs observed in the NOESY, which may be short or long-range in terms of primary 
structure, can later be used to derive distance restraints for structure calculations. These 
increase spectral crowding but can also aid the assignment by the provision of helpful 
short and medium-range NOEs. For apo Bamb_5919 ACP, short-range NH-NH NOEs (i,i+1) 
along the sequence and medium-range NOEs (i+3) were useful in aiding the assignments. 
Overall, the assignment of apo-Bamb_5919 ACP relied upon HNCA, HN(CO)CACB and 
HNCACB. HNCO was an additional help in distinguishing peaks in the recorded 15N-HMQC, 
especially in regions with significant peak overlap. 15N-HSQC-NOESY was primarily used 
to assess the whether the sequential backbone assignments were correct. HCCH-TOCSY 
aided the assignment of residues with ambiguous or very weak C shifts, especially in the 
folded parts of the protein. Hence, the chemical shift table presented in Supplementary 
contains backbone shifts obtained from HNCA, HN(CO)CACB and HNCACB only. 
 
The pH conditions under which the NMR experiments were performed were set 
up to resemble the expected in vivo conditions, i.e. pH = 7. This pH is close to the pI value 
of Bamb_5919 ACP (pI = 7.10). However, there was no visible precipitation detected. CD 
analysis of Bamb_5919 ACP (Figure 3.3) showed that the protein is not negatively 
affected by the temperatures between 30C and 40C, indicating that it should not easily 
degrade in an NMR tube during the acquisition of 3D NMR experiments. 108 out of 142 
residues were assigned (Figure 3.19). The N-terminal part of helix 2 was not assignable 
due to weak C signals in HNCACB. Furthermore, serine residue that anchors the 
phosphopantetheine arm was most likely invisible in 15N HMQC spectrum.  
Examples of sequential walks through 3D experiments used in the assignment are shown 




Figure 3.19 . The assigned 1H-15N-HSQC of apo-Bamb_5919 ACP. The residues that were 








The assignment of the backbone residues allowed a prediction of the secondary structure 
elements using the chemical shift index method124. The programme TALOS+ can be used 
to predict the dihedral angles which in turn are used to predict secondary structure 
elements. TALOS-N is a software package for the prediction of the protein backbone and 
sidechain torsion angles from NMR chemical shifts. TALOS-N uses secondary chemical 
shift alongside sequence information to derive predictions for the backbone angles φ and 
ψ and sidechain angles χ1 with a measure of the uncertainties in each of these 
predictions, and also the secondary structure.  It has been shown that secondary 
chemical shifts for Cα and Cβ of a given residue correlate closely with its φ and ψ torsion 
angles, which therefore permits TALOS to perform this analysis. When given an input file 
of the amino acid sequence and chemical shifts for nuclei within the residues, TALOS will 
analyse the sequence in triplets and search a database for triplets of adjacent residues 
with chemical shifts and a sequence similar to those inputs to attempt to find the best 
match to the current triplet of interest. The database contains backbone torsion angles 
of proteins solved using crystal structures to a resolution of ≤2.2 ̊A. TALOS will then select 
the 10 triplets with the closest matches to the input sequence for each triplet in the query 
sequence. If the 10 triplets exhibit similar φ and ψ backbone angles, their averages can 
be used as angular restraints for the sequence under investigation. In addition to giving 
important structural information, backbone chemical shifts also provide useful insights 
into the flexibility of the backbone in the form of order parameters, S2
124
. 
Figure 3.21 shows the secondary structure prediction per residue for apo-Bamb_5919 
ACP using TALOS+. There was a good agreement with the parts of the homology model 
(Figure 3.1) that were predicted as helical. However, two residues were predicted as -
helical, which might result from a specific conformation of the two residues within the 
helix or misassignment. Furthermore, high S2 values (~0.9) (Figure 3.21A) correlate well 
with the predicted secondary structure. Lower predicted S2 values (~0.6– 0.8) aligned 
with flexible loop regions and unstructured tails. However, residues preceding helix 1, 
which were not predicted as helical in the homology model, were categorised as helical 
by TALOS+. At the same time, S2 values of that region indicated lower flexibility. This 




Figure 3.21 Secondary structure prediction of the assigned Bamb_5919 ACP using TALOS+. 
The analysis comprises predicted S2 values (RCI-S2) and predicted secondary structure 
(ISS).  
 
3.3.3 Bamb_5919 ACP protein backbone relaxation 
  
In addition to providing detailed information about the internal dynamics of the apo-
Bamb_5919 ACP backbone, 15N relaxation experiments were recorded to help the 
backbone assignment of some of the residues that were complicated to assign. Thus, the 
relaxation analysis was used to estimate whether these residues were likely to be located 
in flexible or rigid parts of the protein. Also, the relaxation was used to inspect how the 
assigned residues behave on an NMR timescale.  
 Protein dynamics has increasing relevance to understanding how biological and chemical 
phenomena occur. Macromolecular functions are often associated with energetic 
transition, which is connected with structural changes and molecular flexibility125 .  
In an NMR experiment, after an RF pulse has perturbed the magnetisation from the z -
axis to the xy-plane, the magnetisation does not precess there indefinitely. Relaxation is 
the mechanism by which the nuclear spins return to the equilibrium state. There are two 
key relaxation processes: spin-lattice relaxation (also known as longitudinal relaxation, 
described by rate R1), which describes the return of longitudinal magnetisation back to 
the equilibrium state determined by the Boltzmann distribution, and spin-spin relaxation 
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(also known as transverse relaxation, described by rate R2), which describes the decay of 
transverse magnetisation (in the xy-plane) to zero. 
Many motional processes can be studied by measuring the rate of these relaxation 
mechanisms because relaxation is driven by the random thermal motion of the 
molecules. The motion experienced by the nucleus causes fluctuating magnetic fields 
that interact with the spins. This drives the magnetisation to equilibrium. Such 
fluctuations can be caused by two mechanisms: variations in the dipolar interaction 
between two spins or in the chemical shift anisotropy of the spin itself. The magnitude of 
these types of anisotropic interactions varies due to the reorientation of molecules as a 
result of a dynamic process, which results in the fluctuating magnetic fields. If these 
fluctuations occur at the required frequencies they induce transitions between spin 
energy levels driving the bulk magnetisation back to equilibrium. Because these 
contributions to the relaxation rates originate from random motions they are said to be 
incoherent. The correlation time and correlation function are used to define how quickly 
a magnetic field randomly fluctuates and whether it is at the correct frequency to cause 
relaxation. The correlation time (τc) is defined as the average time taken for a molecule 
to rotate one radian away from its starting position. In solution, proteins often have the 
overall τc on the nanosecond timescale, whereas small molecules will have faster τc on 
the picosecond timescale. The reciprocal of the correlation time (1/τc) provides a guide 
to the average frequency of the motion.  
 
 Spin-Lattice Relaxation (R1) 
 
During an NMR experiment, RF pulses cause the magnetisation to deviate from the 
thermal equilibrium. The return of the longitudinal magnetisation back to this equilibrium 
(i.e. the Boltzmann distribution) is known as spin-lattice relaxation. The time taken for 
this relaxation process to occur is known as the spin-lattice relaxation time (T1), 









The basic method of measuring this relaxation rate involves preparing the system in a 
non-equilibrium state and repeatedly recording the amplitude of the signal in a spectrum 
while varying time t, during which the system relaxes back to equilibrium. The relaxation 
rate can then be extracted from an exponential fit of signal intensity against t. The spin-
lattice relaxation rate contains a large amount of information about the picosecond - 
nanosecond dynamics of a particular nucleus. This is because the motions that are most 
effective at causing R1 are on a timescale that is close to the Larmor frequency (i.e. energy 
gap between the and states), this is typically in the ps - ns range.  
 
Spin-spin Relaxation (R2) 
 
An RF pulse will create magnetisation in the xy-plane. The decay of this transverse 
magnetisation to zero at equilibrium is known as spin-spin relaxation. It is quantified by 







The R1 data recorded for apo-Bamb_5919 ACP showed a similar trend across the 
protein, which suggests that the majority of the assigned residues are characterized by 
similar dynamics on the fast ps-ns time scale (Figure 3.22). However, more significant 
differences are observed in the transverse relaxation rate constants (R2). The parts of the 
protein that were predicted as helical from the homology model displayed shorter 
relaxation times suggesting more structured conformations in these regions. Several 
residues preceding helix 1 also displayed short relaxation times, implying that these 
residues might be also a part of the helix 1, as suggested by TALOS+ prediction (Figure 
3.21). 
Several residues showed unusual R1 dynamics profile (T1709, S1765, A1653, H1762, 
S1765 and S1766). They have been either misassigned or the proper integration of their 






Figure 3.22 Solution-state NMR dynamics data for the apo-Bamb_5919 ACP domain. Grey 
strips show the location of helical elements predicted from the homology model. Data 
were recorded at 700 MHz and 298 K. Error bars represent the standard deviation of the 
measurements. The gaps represent unassigned residues. 
 
T1/T2 ratio can be used as an estimate of the overall rotational correlation time (τc).  All 
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A value for the relaxation-derived τc of 7.93 ns was slightly longer than the expected value 
of 7.4 ns obtained using the general rule of 0.5 ns τc per 1 kDa molecular weight127–129, 
taking into account isotopic enrichment and the presence of affinity purification tags. 
This deviation from the ideal value is not large enough to imply oligomerization of apo-
Bamb_5919 ACP, but may reflect a non-spherical shape of the monomeric protein and 
could also arise from the presence of long unstructured termini. This was in accordance 
with the obtained analytical size-exclusion chromatogram that was additionally used to 
inspect the oligomerisation state of the apo-Bamb_5919 ACP in the buffer conditions 
used for NMR studies (Figure 3.23). Namely, the protein mass of both Bamb_5919 ACP 
and Bamb_5919 KS0 calculated based on the elution volume corresponded to trimer. This 
was not surprising as τc suggested that apo-Bamb_5919 ACP was not perfectly globular. 




Figure 3.23 Analytical SEC analysis of Bamb_5919 ACP and Bamb_5919 KS0. 
 
The disordered termini are highly mobile on fast ps-ns timescale compared to the 
structured core, as indicated by lower heteronuclear NOEs (Figure 3.22). 
 
3.3.4 15N-HSQC analysis of apo- to holo- conversion of Bamb_5919 
 
To get an insight into which residues are affected by the conversion of Bamb_5919 ACP 
from apo to holo form, 1H-15N-HMQC spectra were recorded for each form (Figure 3.24A). 
The assignments of the backbone residues were transferred to the 15N-HMQC spectrum 
recorded for holo sample. The differences in peak shifts between two protein forms were 
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Figure 3.24 Chemical shift difference between apo and holo form of Bamb_5919 ACP. A) 
The overlap between 15N-HMQC spectra recorded for apo and holo forms. B) Average 
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chemical shift differences, Δδav, shown between holo and the apo form, C) The residues 
with Δδav above the average in B) are shown mapped on the homology model of 
Bamb_5919 ACP.  
 
The chemical shift perturbations observed on conversion could be interpreted as 
evidence that the Ppant arm mostly affects the conformations of peaks that are oriented 
towards the turn between the first two helices. Several residues helices 3 and 4 were also 
affected (Figure 3.24 B). A similar pattern was observed in ACPs from other systems124,130.  
 
Investigating Bamb_5919 ACP:Bamb_5919 KS0 interface by solution-state NMR 
titrations 
 
NMR titrations were used to map the binding interface between apo and holo forms 
Bamb_5919 ACP and Bamb_5919 KS0 domain. Due to its size, it was not possible to obtain 
the backbone assignment of Bamb_5919 KS0. For that reason, it was possible to monitor 
the effects of binding only on Bamb_5919 ACP. 
Generally, NMR can be used to study protein-ligand and protein-protein interactions in 
several ways. Typically, an NMR study of a protein-protein interaction starts with titration 
experiments, in which an isotope labelled protein is observed (for example using the 1H-
15N-HSQC) in the presence of increasing concentrations of an unlabelled binding partner. 
If the two proteins interact, the labelled protein will undergo chemical shift perturbations 
(CSPs) caused by changes in the chemical environment around residues that are affected 
during the interaction. CSPs can be used to map the binding interface which is known as 
chemical shift mapping124. During a titration experiment, the proteins exchange between 
free and bound states at a rate which depends in part upon the binding affinity and the 
sample temperature. The exchange between free and bound states occurs at different 
rates, which can be categorized into three exchange regimes: fast, intermediate and slow. 
The absolute rate of exchange is not relevant for analysis, but the rate of exchange (kex) 
relative to the difference in the chemical shift (or frequency, Δω) between a residue in 
the free and bound states (Figure 3.26). When kex > Δω, the exchange is said to be in the 
fast regime, when kex < Δω the exchange is slow and when kex ≈ Δω the exchange is 
intermediate. For a residue exchanging within the fast regime, a single peak is observed, 
which represents a population-weighted average between the free and bound states. The 
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fast exchange typically occurs for interactions with a Kd > 3 µM and is recognised in a 
two-dimensional spectrum such as the 15N-HSQC when a peak appears to shift from one 
position to another with increasing concentrations of ligand. For a residue exchanging in 
the slow regime, two peaks are observed. One peak remains at the original position, 
whilst the other one emerges at the new position. The intensity of the original peak 
decreases as the intensity of the new peak increases. This happens because the 
population of protein in the free state decreases and population in the bound state 
increases. Intermediate exchange is characterised by chemical shift changes that are 
accompanied by line broadening, which can result in the complete disappearance of a 




Figure 3.25 Exchange regimes in NMR. The diagram illustrates the slow, intermediate and 
fast exchange of a single resonance between two different conformational states (ωfree 
and ωbound). In the slow regime, two peaks are observed. In the fast regime, a single peak 
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is observed at an average position. Kex increases with temperature and Δω increases with 
a magnetic field. Examples are shown of each regime in a 1H-15N HSQC. 
 
NMR titrations were used to analyse the interaction between both apo and holo-
Bamb_5919 ACP to inspect whether the presence of a covalently bound prosthetic 
group affects the interaction profile.  
Upon addition of Bamb_5919 KS0, no peak shifts were observed. The intensity of several 
peaks in the spectrum was decreasing along the ligand concentration gradient (Figure 
3.27). 
This indicated that the interaction was following a slow exchange regime. However, no 
new peaks were forming in the spectrum. This was due to an increase in the correlation 
time of 15N-Bamb_5919 ACP upon complexation with Bamb_5919 KS0 so the resulting 
complex was ~ 90 kDa compared to 15 kDa of the unbound Bamb_5919 ACP. The rate of 
transverse relaxation T2 is proportional to the correlation time so the signal intensity is 
expected to decrease with slower tumbling.  
The peak intensity decay rates can be used to calculate Kd of individual residues. 
However, these values should not be treated as exact values, such as Kd values obtained 
from BLI or ITC. Still, their analysis was used to inspect whether the overall pattern of the 
backbone Kd values would be similar between apo and holo datasets and to monitor 
which peaks are the most affected by the presence of Bamb_5919 KS0. The Kd values that 
were obtained for four replicates of apo sample were relatively consistent across parts 
of the protein that were predicted as helical (Kd = ~ 60 M)(Figure 3.28). Contrarily, the 
Kd values of the residues likely to be in the flexible part of the protein were inconsistent 
and higher. These peaks were mostly located in the region of HMQC with a significant 
level of signal overlap and were thus not possible to properly integrate. Their fits were 
not good in some cases (Supplementary). The relative Kd values obtained for three 
replicates of holo samples were higher compared to the Kd pattern of apo samples.  
Altogether, this suggested the stronger binding of holo-Bamb_5919 ACP compared to 
apo-Bamb_5919 which was consistent with the BLI data (Figure 3.9), but also confirmed 





Figure 3.26 1H-15N HMQC titrations of apo- and holo-Bamb_5919 ACP with the increasing 
concentrations of Bamb_5919 KS0. The addition of ligand caused some peaks to decrease 
in intensities. The intensities of other peaks, the majority of which was located in the part 





Figure 3.27 Local apparent Kd values obtained from solution-state NMR titrations. The 
plots represent all replicate experiments recorded for titrations of A) apo-Bamb_5919 ACP 
and B) holo-Bamb_5919 ACP with Bamb_5919 KS0. 
 
Next, to distinguish which individual residues experience the highest peak intensity decay 






and plotted in Figure 3.26. To inspect the location of the residues that had the highest 
decay rate (higher than the mean + standard deviation, as described in Chapter 2), they 
were mapped onto the homology model of apo-Bamb_5919 ACP for both apo and holo 






Figure 3.28 Local apparent Ka obtained from NMR titrations of apo-Bamb_5919 with 
Bamb_5919 KS0 projected onto the structure of the homology model of holo-Bamb_5919 
ACP (Figure 3.1). Each dataset is presented. Majority of residues with a higher than 
average local apparent Ka were located in the parts of the protein that were predicted to 





Figure 3.29 Local apparent Ka obtained from NMR titrations of holo-Bamb_5919 with 
Bamb_5919 KS0 projected onto the the homology model of apo-Bamb_5919 ACP (Figure 
3.1). The results obtained for four replicate datasets are shown separately. 
 
Based on the data presented in Figures 3.29 and 3.30., the residues that are the most 
affected by the presence of Bamb_5919 KS0 were located in the core of the protein and 
do not seem to form a surface patch. This indicated conformational change in 
Bamb_5919 ACP upon binding. Furthermore, to compare the patterns of affected 
residues in all apo and holo datasets, Figure 3.30 was created. Again, the analysis of Ka 
values demonstrated that N and C-termini probably do not interact with KS0. Thus, their 





Figure 3.30 Higher than average local apparent Ka projected onto homology model of 
Bamb_5919 ACP. The protein sequence, not including termini, is also shown. The red 
squares represent the residues with the highest intensity decay upon addition of ligand in 




Even though all the helices were affected to some extent in both apo and holo proteins, 
several hydrophobic residues were the most affected in all datasets. These residues were 
L1662 and I1666 that are located in helix 1, as well as the residues in helix 4 (I1718 in apo 
and L1721 and I1722 in holo sample). Thus, the Bamb_5919 ACP hydrophobic pocket 
might be crucial for recognition of Bamb_5919 KS0 through hydrophobic contacts. The N-
terminal part of helix II could not be properly assigned so it was not possible to monitor 
the effect of the presence of Bamb_5919 KS0 on that part of the protein. However, there 
were no significantly affected peaks that were unassigned, which suggests that the 
unassigned part of helix 2 might not be significantly affected by the addition of 
Bamb_5919 KS0. 
However, several studies have suggested that negatively charged, solvent-exposed 
amino acids within helix II ACPs may have important roles in protein-protein interactions 
and act as a recognition motif for the interaction of different types of ACPs with their 
partner domains52,131–136. For example, the docking model of type II E. coli ACP interacting 
with KS III showed that this interaction is mediated by a hydrophobic and positively 
charged surface patch on KS III which docks with a partly hydrophobic and negatively 
charged surface on the helix II of ACP133. The study also highlighted that the Glu, which is 
located just above Ser in ACP forms a crucial ionic interaction adjacent to the KS active 
site entrance.   
Furthermore, photo-crosslinking assay and mutagenesis experiments of the same system 
suggested that the charged residues in helix II are crucial for its interaction with the 
ketosynthase137. The recent study of the same system highlighted that Asp at the C-
terminal and Glu at the top N-terminal part of the helix II are particularly important for 
ACP-KS interaction135. The molecular dynamics experiments in the same study also 
showed that ACP in the apo state loses its ability to maintain several of the salt bridge 
contacts observed in the crystal structure. However, upon being activated to its holo 
state, salt bridge contact times increase on the bottom of helix II. Interestingly, upon 
loading of the Ppant arm with a substrate, ACP helix III begun to make new interactions 
with the ketosynthase that were not found in the crystal structure. A similar effect was 
observed in holo-Bamb_5919 ACP where T1709 in helix III seems to be more affected by 
the presence of Bamb_5919 KS0 in comparison with apo-Bamb_5919 where the residues 
in helix III did not seem to undergo a local conformational change. 
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For type I PKS, which is the same type of PKSs as enacyloxin PKS, studies that were focused 
on the protein recognition features of ACP domains also identified helix II as potentially 
important in KS–ACP interactions138,91. It was even proposed that several charged 
residues on helix II might enable ACPs to differentiate between their partner KS 
domains139.  
However, in DEBS type 1 PKS (a prototypical type of PKSs described in Chapter 1), in 
addition to helix II, the N-terminal part of helix I in ACP2 from the third module seems to 
be the primary specificity determinant during intermodular chain translocation140 (Figure 
3.31). The NMR titrations between ACP2 and the didomain comprised of the interacting 
KS and AT, KS3-AT2, also pointed that the residues in helix 2, in addition to the loop 
connecting helix 2 and 3, was the most affected by the binding to the didomain141.  
Moreover, the same study proposes that during intermodular chain translocation ACP2 
and KS3 engage each other via a two-step mechanism. In the first step, acyl-ACP2 docks 
onto module 3 via protein–protein interactions centred on helix I of the ACP as well as 
the short peptide sequence that lies beyond the C-terminal end of the core ACP domain. 
In the second step, insertion of the acyl chain into the KS active site leads to further 





Figure 3.31 Proposed docking model for ACP2 (dark grey) onto [KS3][AT3] (green) during 
the chain transfer mode of interaction in DEBS141. Apo-ACP2 residues with solvent-
exposed side chains whose backbone HSQC peaks significantly decreased in intensity upon 
addition of [KS3][AT3] are highlighted in red. These residues are L24, R26, N62, R61, T68, 
and T75. Salt bridges and hydrogen-bonding interactions between the ACP2 residue (red) 
and [KS3][AT3] partner residue (blue) are highlighted in orange. Unassigned ACP2 
residues are highlighted light grey. The figure was taken Charkoudian LK, Liu CW, Capone 
S, et al., 2011. 
 
Overall, solution-state NMR provided information about the residues of Bamb_5919 ACP 
that were the most likely to be involved in the interaction with Bamb_5919 KS0, i.e. 15N-
Bamb_5919 KS0. However, the same solution-state NMR approach could not be used to 
characterise the binding interface on Bamb_5919 KS0. Attempts have been made 
previously to crystallise KS0  by Dr. J.C.Milligan, a member of collaborating prof. Tsai 
group142. However, the diffraction quality of KS0 crystals was found to be relatively poor. 
Combining datasets from several different crystals enabled processing to a resolution of 
3.05 Å.. Also, It was not possible to obtain phases by using molecular replacement.  
Therefore, as the X-ray crystal structure of enacyloxin module 10 KS0 is unknown, it was 




3.3.5 The solid-state NMR analysis of the Bamb_5919 ACP:Bamb_5919 KS0 complex 
 
Solution-state NMR analysis of proteins and protein-protein complexes is limited by the 
broadening of resonances at higher molecular weights and the losses of spectral 
resolution and sensitivity. For that reason, it is not possible to observe the signals 
originating from Bamb_5919 ACP backbone when the complex with Bamb_5919 KS0 is 
formed. It is only possible to determine which residues are likely involved in the 
interaction with the ligand, which was attempted in the previous section. Thus, the 
information about the shifts and conformation of these residues in the complex cannot 
be determined by solution-state NMR. 
Solid-state NMR spectroscopy has emerged as one of the few techniques that can provide 
atomic-level structural information for these types of systems. Solid-state NMR takes 
advantage of the fact that the line widths in solids do not depend on the size of proteins 
as they do in solution. Hence, by using solid-state NMR to study complex between 
Bamb_5919 ACP and Bamb_5919 KS0 it might be possible to get an NMR fingerprint of 
their interface in the complex.  
The ability to apply solid-state NMR to study large complexes became possible only 
recently thanks to the progress facilitated by advances in sample preparation and NMR 
methodology.  Solid-state NMR was applied to study for example amyloid fibrils143, 
membrane proteins144 and complex molecular assemblies145. With regards to sample 
preparation, an important recent development was the introduction of FROSTY (freezing 
rotational diffusion of protein solutions at low temperature and high viscosity) 
sedimentation by ultracentrifugation as a method to prepare homogenous protein solid-
state NMR samples that yield narrow resonances suitable for detailed quantitative 
studies146. This approach has enabled the solid-state NMR study of a very large, 1.1 MDa, 
highly symmetric 7777-11S multimeric complexes from the 20S proteasome. So far, 
the only asymmetric system studied by this approach has been the complex between 
Bamb_5919 PCP and Bamb_5915 C, which was analysed by Dr. A. Gallo and Dr. S. Kosol, 
members of Lewandowski group147. FROSTY was also used in this PhD project to prepare 
the sediments between Bamb_5919 ACP and Bamb_5919 KS0.  
For solid-state NMR investigation, the protein samples have to be properly hydrated, 
which is crucial for their activity, folding and dynamics148–153. On the other hand, sample 
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dehydration can reduce the spectral resolution. Sedimentation by FROSTY can be also 
used to immobilise the proteins by centrifugation while retaining the homogeneous local 
environment, which is useful if the sample cannot be crystallised. The sample has to be 
evenly packed into the rotor to maximise the sample quantity. Hydrated proteins are 
semi-solids and typically stick to the tools used to pack dry samples, while simultaneously 
being too viscous to be transferred using a pipette. Moreover, sedimented proteins must 
be transferred to the rotor with as little waste of the costly sample as possible, while also 
not changing the hydration of the protein. In the Lewandowski lab, proteins are usually 
packed into 0.7 and 0.8 mm rotors manually by using a spatula and into 1.3 mm rotors 
using a benchtop centrifuge.  
 
Solid vs. solution-state NMR 
 
The NMR interactions that affect the Larmor frequency of a nucleus are the Zeeman 
interaction (the interaction with an external magnetic field B0)154, dipolar coupling and 
chemical shift anisotropy. The precise Larmor frequency of the nucleus in a magnetic field 
does not only depend upon the type of nucleus (i.e. gyromagnetic ratio), but also the 
surrounding environment. The chemical shift or chemical shielding, like the Larmor 
frequency, is proportional to the external magnetic field. Electrons are not spherically 
distributed around a nucleus, therefore shielding from the electrons will be anisotropic. 
This means that the orientation of the nucleus with respect to the B0 field will affect the 
chemical shift, which is known as chemical shift anisotropy (CSA). In the solution state, 
where the molecules are rapidly tumbling, the anisotropy is averaged out and just the 
isotropic chemical shift is observed. But in the solid-state CSA is an important factor to 
consider because the molecules will be in different orientations with respect to the B0 
field and each will produce a slightly different chemical shift. The resulting peak will  be a 
superposition of all orientations and have a broad shape. In the solid state the effects of 
J-coupling are rarely resolved, because their influence usually has the smallest 
magnitude. Dipolar coupling is a through-space interaction between a pair of dipole 
moments. Like CSA, this interaction is also anisotropic: each orientation will give a 
different splitting, which causes the broadening of an overall NMR signal. The dipolar 
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interactions are distance-dependent so a spin will have the strongest dipolar interactions 
with those closest in space.  
 
Magic angle spinning 
 
Magic angle spinning (MAS) is applied in solid-state NMR experiments to remove the line-






Where θ is the angle between the B0 field and the CSA principal axes. The rotation of a 
solid sample at 54.74° to the B0 field reduces Equation 3.10 to zero. This angle has been 
named the magic angle (Figure 3.33). To average CSA or dipolar interactions, the 
frequency of the magic angle spinning (MAS) has to be larger (faster) than the size of the 
interaction. For example, homonuclear dipolar couplings are more difficult to average 
out compared to heteronuclear dipolar couplings. MAS of up to 60 kHz is typically used 
in protein solid-state NMR experiments, however more recent advances in NMR 
equipment now allow for MAS up to 150 kHz (Figure 3.33).  
 
 
Figure 3.32 Schematics showing the MAS rotor oriented at the magic angle with respect 
to the external magnetic field, B0. Also shown are rotors used in MAS NMR experiments, 






The signal from a typical protein solid-state NMR experiment is low so the same 
experiment has to be repeated many times to increase the signal-to-noise ratio. Cross 
polarisation (CP) is a technique used to provide information on different nuclei in a single 
experiment. CP is also used to increase the signal-to-noise ratio and decrease 
experimental time. CP involves the transfer of magnetisation from the nuclei of an 
abundant isotope (e.g. 1H) to a less abundant isotope, such as 13C or 15N. The achieved 
signal enhancement depends on the experimental setup, including the optimisation of 
the pulse powers and lengths. After running the pulse sequence the magnetisation needs 
return to equilibrium before repeating the experiment, which is T1 dependent. A recycle 
delay, which is at the end of a pulse sequence, allows time for T1 relaxation. This strong 
pulse called spin-lock ensures that the magnetisation remains along the axis as the RF 
field strength is greater than any offset that would normally cause deviation from this 
axis. The spin-lock pulse is applied along the same axis as the magnetisation vector. 
1H-X CP starts with a 1H 90° pulse which brings the 1H spins from the z-axis into the xy-
plane. Spin-lock pulses are applied simultaneously on both the 1H nuclei and the X nuclei 
for a length of time termed the contact time, which usually lasts a few ms. Magnetisation 
is transferred from the 1H nuclei to the X nuclei during the contact time (Figure 3.34). The 
detected signal originates from X. 1H decoupling is applied during the acquisition time.  
 
Figure 3.33 1H-X CP pulse sequence. 
 
The polarisation transfer occurs when the Hartmann–Hahn matching condition is 
satisfied, which is when the nutation frequencies of the nuclei 1H and X are matched by 
the choice of appropriate RF field strengths. Fulfilling the Hartmann-Hahn condition will 
cause both the 1H and X nuclei to have the same energy gap between their spin states, 
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so that the 1H-X dipolar coupling allows redistribution of energy between them and 
ultimately the transfer of magnetisation from 1H to X.  
 
Sedimentation of holo-Bamb_5919 ACP:Bamb_5919 KS0 complex 
 
The initial sedimentation conditions were selected based on the calculations made by Dr. 
Rebecca Stevens from Lewandowski lab (Figures 3.34 and 3.35). However, the sample 
packing was performed manually, without the use of packing tools (MLS-50 and MLA-
150). The initial sedimentation speed was thus set to 700 000 g for 24 hours.  
 
Figure 3.34 Calculated conditions required to fully sediment a protein into a 0.7 mm 
rotor using the MLS-50 tool at 258,000 x g (black) and the MLA-150 tool at 700,000 x g 
(grey). The graph indicates the minimum concentration of protein needed for a range of 





Figure 3.35 The time required for complete sedimentation using the MLS-50 and MLA. 
Figure 3.21: The time required for complete sedimentation using the MLS-50 and MLA-
150 packing tools at 258,000 x g and 700,000 x g, respectively. The figure was taken from 




Compared to solution-state NMR, produces a much weaker signal. The amount of 15N 
labelled protein in the sediment and being subsequently packed into the rotor is much 
smaller compared to the amount of protein inside solution-state NMR tube. For that 
reason, every effort was made to ensure the highest possible concentration of 15N-
Bamb_5919 ACP:Bamb_5919 KS0 complex inside the rotor. 
Only holo-Bamb_5919 ACP was used solid-state NMR analysis as the kinetic data 
indicated that this form of the protein binds stronger to Bamb_5919 KS0 (Figure 3.9). The 
samples that were prepared by mixing 15Nholo-Bamb_5919 ACP and Bamb_5919 KS0 1:1 
and 1:2 ratio (in the excess 15Nholo-Bamb_5919 ACP) did not yield a good enough NMR 
signal. This indicated that the sediment contained mostly a larger binding partner, 
Bamb_5919 KS0. To push the equilibrium towards the complex formation, the ratio was 
increased to 5:1 which resulted in a detectable signal. In addition, sample pH was 
increased to 7.5 to avoid unwanted precipitation during sedimentation which impairs 
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sample homogeneity. An example of a proton spectrum recorded on such a sample is 
shown in Figure 3.36.  
The sedimentation at 700000 g produced very solid gel sediment that was not feasible 
for manual packing into the rotors. The sedimentation at a lower speed, 500000 g, yielded 
a more viscous sample, which was also properly hydrated. Figure 3.36 shows the 
spectrum which was sedimented at that speed. In addition, to speed up the acquisition 
of experiments and thus enhance the signal, the samples were exposed to paramagnetic 
tag gadolinium diethylenetriaminepentaacetic acid bismethylamide (Gd(DTPA-BMA)). 
Namely, paramagnetic relaxation enhancing agents decrease 1H T1 relaxation time and 
allow for faster repetition of experiments and an increase in signal to noise ratio and are 
often used to speed up acquisition in solid-state NMR146. Gd(DTPA-BMA) is widely used 
in Lewandowski lab for protein sample preparation154. 
Ideally, the recorded CP spectrum would resemble an HSQC, i.e. all backbone 
residues involved in the formation of the Bamb_5919 ACP_Bamb_5919 KS0 complex 
should give a signal. However, this has not yet been achieved for inhomogenous protein 
complexes such as ACP-KS0. The 2D 1H-15N CP spectrum recorded at 60 kHz and 500 MHz 
showed the presence of several peaks that were possible to distinguish (Figure 3.37). The 
signals in 1H-15N CP originate only from immobilised residues within the protein 
backbone, i.e. those in the folded regions. Thus, only the residues in structured parts of 
the protein are likely to yield a peak in the spectrum 154. Therefore, it was assumed that 
those signals originate from residues that are involved in the interaction with Bamb_5919 
KS0. Unfortunately, it was later discovered that the cooling unit on a spectrometer 
unexpectedly switched off during the experiment which heated up the sample to 50°C. 
Based on CD data (Figures 3.4 and 3.5), the increase in temperature probably did not 
have a profound effect on the stability of Bamb_5919 ACP. However, it most likely had a 






Figure 3.36 1H NMR spectrum of Bamb_5919 ACP in the complex with Bamb_5919 KS0. 
The sample was well hydrated, as indicated from the water peak shown in A).  The 







Figure 3.37 2D 1H-15N CP correlation spectrum of holo-Bamb_5919 ACP domain in a 
sedimented complex with Bamb_5919 KS0. The sample was exposed to high temperature, 
which might have a negative effect on the protein fold of Bamb_5919 KS0. 
 
To improve spectral resolution, the sample was further analysed at higher MAS. The 2D 
1H-15N CP spectra recorded at 90 kHz and 600 MHz also indicated that some peaks were 
possible to resolve (Figure 3.38). However, recording the same spectra with a higher 
number of scans did not yield the peaks with the same shift so it was not possible to 
reproduce the spectra and ensure that they are real peaks (Figure 3.39 – bottom 
spectrum). The overlaid 2D 1H-15N HMQC spectrum recorded for isolated holo-Bam_5919 
ACP and 1H-15N CP spectra recorded for its complex with Bamb_5919 KS0 (Figure 3.38) 
show that CP spectrum covers the parts of HMQC spectrum that do not have any peaks. 
This implied that some peaks shifted significantly when in complex with Bamb_5919. This 
suggested that these peaks undergo a conformational change. This was in agreement 





Figure 3.38 An overlay between 2D 1H-15N CP of holo-Bamb_5919 ACP domain in a 
sedimented complex with Bamb_5919 KS0 and unbound 2D 1H-15N HSQC. Spectrum was 
recorded at 600 MHz, 100 kHz. 
 
Unlike CP, solution-state NMR-like experiment INEPT detects only signals originating from 
highly dynamical and flexible residues, which are usually located in terminal parts of the 
protein154 that are most likely not rigidified by the presence of a binding partner. The 
INEPT spectrum of Bamb_5919 ACP:Bamb_5919 KS0 was overlapped with the HMQC 
spectrum of unbound ACP (Figure 3.39, spectrum in green). The INEPT peaks could be 
overlapped with the peaks in HMQC that were located in the flexible terminal parts of 
unbound Bamb_5919 ACP. This implied that they are not affected by complex formation, 
which was again in line with the results of solution-state NMR titrations. However, only 
one sedimented sample generated signals in the INEPT experiment so it was not possible 





Figure 3.39 Figure 3.24 A) An overlay of 2D 1H-15N CP and INEPT of holo-Bamb_5919 ACP 
domain in a complex with Bamb_5919 KS0. These solid-state NMR spectra were also 
overlapped with a solution-state 1H-15N HMQC of an isolated Bamb_5919 ACP. INEPT 
overlaps with the residues in HMQC spectrum which are in the disordered part of 
Bamb_5919 ACP (termini) B) Overlap between the two CP recorded with a time difference 
of several hours. The spectra cover the same region in CP, but the shifts of the 
distinguishable peaks are not identical, which means that it was not possible to reproduce 
the spectra and the individual peaks are not real. The solid-state spectra shown in the 
upper figure were recorded at 600 MHz, 90 kHz. The bottom CP spectra were recorded at 








Majority of the assigned Bamb_5919 ACP backbone residues were predicted by 15N 
relaxation experiments and TALOS+ analysis to be located in the parts of the protein that 
were categorised as helical by Phyre+ homology model. Solution-state NMR titrations 
indicated that only the residues located in helices are affected by the binding with 
Bamb_5919 KS0, not N and C terminal parts of Bamb_5919 ACP. These residues were 
located in the core of the protein, which suggested that Bamb_5919 ACP undergoes 
conformational exchange upon binding to Bamb_5919 KS0. Solid-state NMR analysis of 
the Bamb_5919 ACP:Bamb_5919 KS0 interface further suggests that Bamb_5919 ACP 
changes its conformation in the complex, compared to its unbound form. Kinetic studies 








Chapter 4 - The interaction of enacyloxin module 10 non-





Chapter 3 provided information about the interface between Bamb_5919 ACP and 
Bamb_5919 KS0. However, as a second step towards the understanding of what structural 
characteristics of enacyloxin module 10 ACP make it an improper interaction partner with 
the C domain, Chapter 4 provides an insight into the interaction between PCP and KS0.  
As discussed in Chapter 2, PCPs are small (∼ 10 kDa) proteins that are characterized by a 
highly conserved signature motif of GxxSL/I. The serine residue in this motif is the site for 
4′-phosphopantetheinylation. PCP domain shares the canonical four-helix arrangement 
with acyl carrier proteins from PKS systems. This domain can adopt multiple 
conformations, which is thought to stabilise specific conformations for a functional 
interaction155. 
The solution-state NMR structure of Bamb_5919 PCP (10.7 kDa) also reveals four -
helical fold that is typical for PCPs, with disordered regions of residues at both N- and C-
terminus (Figure 4.1) 147. To get insights into the interaction between Bamb_5919 PCP 
and Bamb_5919 KS0, the approach used to analyse the interaction between Bamb_5919 






Figure 4.1 The NMR structure of holo Bamb_5917 PCP (PDB:5MTI)147. 
 
4.2 The analysis of the interaction between Bamb_5917 PCP and Bamb_5919 KS0 
 
4.2.1 The BLI analysis of Bamb_5917 PCP:Bamb_5919 KS0 interaction 
 
For comparative purposes, the reaction buffer was the same as the buffer used for NMR 
titrations of Bamb_5919 ACP and Bamb_5919 KS0. Bamb_5917 PCP was titrated with 
increasing concentrations of Bamb_5919 KS0. The binding was evident from the increase 
in signal upon addition of analyte (Supplementary S.3). Fitting of the data revealed the Kd 
of 0.19  0.02 µM (an average value of the duplicate measurements) for the binding of 
apo-Bamb_5917 PCP and 0.18 µM  0.02 µM for holo-Bamb_5917 PCP (an average value 
of the triplicate measurements, Figure 4.2). This was an indication that the addition of 
prosthetic arm does not significantly affect the strength of the binding between the two 





Figure 4.2. BLI steady-state analysis profile of the interaction between apo-Bamb_5917 
ACP and holo-Bamb_5917 PCP with Bamb_5919 KS0 (triplicate measurements). The 
binding curves can be found in Supplementary S.3.  
 
The best data fitting was achieved with 2:1 fitting, which indicated non-ideal binding. The 
reasons that might underly this result are discussed in Chapter 3.  
Next, ITC was used to get information about the binding enthalpy. The Kd value obtained 
from the fitting revealed a strong binding between Bamb_5919 PCP and Bamb_5919 KS0, 
which was consistent with BLI data (Figure 4.2). The binding was also an endothermic 
reaction, which suggests that the binding is mainly mediated by hydrophobic interactions. 
However, the stoichiometry of binding was far off the 1:1 binding profile and there was 




Figure 4.3 ITC analysis of the binding between Bamb_5919 ACP and Bamb_5919 KS0. A) 
The measurement obtained for apo-Bamb_5919 ACP. B) The results obtained for two 
replicate apo-Bamb_5919 ACP measurements. 
 
4.2.2 NMR analysis of apo to holo conversion of Bamb_5919 PCP 
 
The difference between backbone chemical shifts in 1H-15N HMQC recorded for apo and 
holo-Bamb_5919 PCP was used to analyse the effect of phosphopantetheinilation on its 
backbone (Figure 4.4).  The residues in the vicinity of helix 2 conserved serine, which acts 
as an acceptor site for Ppant, together with several residues in helix 3, were the only 
residues that were prominently shifted. This was most likely due to the local changes in 
electron density caused by the covalently bound phosphate and the pantetheine. The 
same effect was observed in NMR studies of aryl-acid-loaded PCP from yersiniabactin 
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NRPS156 and the pyrrole-loaded PCP from pyoluteorin NRPS156 which suggested that 
Ppant arm interacts with helices 2 and 3. 
Besides, NMR structures of type I PCPs isolated from the NRPSs revealed three 
interchanging conformations, the A state for apo-PCP (without Ppant), H state for holo-
PCP and a conformation shared by both apo- and holo-PCP, the A/H state155,157.   
 
4.2.3 Investigating the interaction between Bamb_5917 PCP and Bamb_5919 KS0 by 
solution-state NMR titrations 
 
To get insights into the effect of the binding with Bamb_5919 KS0, a series of 1H-15N-
HMQCs of apo- and holo-15N-Bamb_5917 PCP were recorded in the presence of 
increasing concentrations of unlabelled Bamb_5919 KS0. The spectra of unbound and 
bound Bamb_5917 PCP are shown overlaid in Figure 4.5. In both spectra, some residues 
were in a slow exchange upon addition of Bamb_5919 KS0. These peaks were tracked and 
their changes quantified as a function of Kd (Figure 4.6) to map the binding interface. 
There were no overlapping peaks so it was possible to extract integrals for all peaks. The 
absence of newly formed signals suggested that the complex formation resulted in line 
broadening as the size of 15N-Bamb_5919 PCP:Bamb_5919 PCP complex was 85 kDa, 
compared to 10.7 kDa of the unbound protein. The extracted local Kd values were 





Figure 4.4 Chemical shift difference between apo and holo form of Bamb_5917 PCP. A) 
The overlap between 15N-HSQC spectra recorded for apo and holo forms. B) Average 
chemical shift differences, Δδav, shown between holo and the apo form, C) The residues 









Figure 4.5 15N-1H HMQC spectra of titration of apo and holo-Bamb_5919 PCP with 




Figure 4.6 Local apparent association constants, Kd, obtained from titrations of apo and 





The apo-Bamb_5917 PCP residues that were significantly affected by the binding to 
Bamb_5919 KS0 were located in helices (Figure 4.7). However, apart from being oriented 
towards the protein core, they seemed to form a surface patch. In order to inspect 
whether the surface contacts might be involved in the binding, the data recorded for 
holo-Bamb_5919 PCP were also analysed (Figure 4.8). This analysis, however, showed 
that the residues with the highest peak intensity decrease are located in the core of the 
protein and do not form a surface patch. This indicated that holo-Bamb_5917 PCP 
undergoes a conformational change upon binding with Bamb_5919 KS0, which is 
consistent with a highly dynamic nature of PCPs who are known to undergo 
conformational rearrangements when interacting with their domain partners158,159.  
For example, the study of PCP-TE didomain protein from E. coli enterobactin synthetase 
EntF NRPS subunit160 and a protein complex between a type II TE, SrfTEII, from Bacillus 
subtilis NRPS and Type I PCP from the third module of the tyrocidine A synthetase161 also 
led to the conclusion that the PCP and/or the catalytic domains undergo large 
conformational changes upon interaction. 
It is not possible to conclude from the presented results whether the contact between 
apo-Bamb_5917 PCP is guided by the surface patch in any way. It clear, however, that 






Figure 4.7 Local apparent Ka values projected onto the structure of apo-Bamb_5919 PCP. 
The residues highlighted in red have a Ka that is higher than one standard deviation based 
on the obtained data from the analysis of the titrations of apo-Bamb_5917 PCP with 





Figure 4.8 Local apparent Ka values projected onto the structure of holo-Bamb_5919 PCP. 
The residues highlighted in red have a Ka that is higher than one standard deviation based 
on the obtained data from the analysis of the titrations of holo-Bamb_5917 PCP with 







Based on solution-state NMR titrations, the interaction between Bamb_5917 PCP and 
Bamb_5919 KS0 follows a slow NMR exchange regime, which is a characteristic of strong 
binding. This was also confirmed by BLI and ITC experiments. The residues that are most 
affected by the interaction are located in the protein core, which indicates 









Chapter 5 - Analysis of the structural differences between 
Bamb_5919 ACP and Bamb_5917 PCP which affect their 




Chapter 3 and 4 focused on the interaction profiles of enacyloxin module 10 ACP:KS0 and 
KS0:PCP separately. This chapter compares the results obtained from both of the chapters 
and suggests which structural characteristics of ACP make it an inappropriate binding 
partner with C domain, also based on a recently published Lewandowski/Challis lab 
analysis of the PCP-C domain interface147. It has been mentioned in Chapter 3 that the 
structure of module 10 KS0 has not yet been determined, so this chapter will only discuss 
the binding interface from a perspective of carrier proteins.  
Besides, competitive NMR titrations were used to determine whether PCP and ACP bind 
KS0 simultaneously or competitively, i.e. at the same or different location. 
 
5.2 Competitive NMR Titrations 
 
Firstly, unlabelled Bamb_5919 KS0 was titrated into the solution of holo-15N-Bamb_5919 
ACP and the backbone NH groups monitored using HMQCs (Figure 5.1). Unlabelled holo-
Bamb_5917 PCP was then added to the complex but no changes were seen, suggesting 
that Bamb_5919 ACP did not bind Bamb_5919 KS0 in the presence of Bamb_5919 PCP 
(Figure 5.1). Firstly, the intensity of some of the peaks decreased upon binding to 
Bamb_5919 KS0. This was expected as it was, determined in Chapter 3 that Bamb_5919 
ACP interacted with Bamb_5919 KS0, which resulted in decreased intensity of some of 
the peaks. However, those peaks did not regain its intensity even after addition of a 3-
fold excess of Bamb_5919 PCP, indicating that the Bamb_5919 ACP was not displaced by 
Bamb_5919 PCP on Bamb_5919 KS0 interface. These experiments were recorded at 
sufficiently high protein concentrations (100 µM 15N-Bamb_5919 ACP, 100 µM 
Bamb_5919 KS0, 200 µM Bamb_5919 PCP) to be more than the Kds of the individual 
interactions (Bamb_5919 ACP:Bamb_5919 KS0 Kd = 0.23 µM, Bamb = 0.18 µM). The 
reverse titrations further confirmed that Bamb_5919 ACP and Bamb_5919 PCP did not 
bind competitively (Figure 5.2). 
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Visual inspection of HMQC spectra shown in Figure 5.1 and 5.2 was followed up by the 





Figure 5.1 1H-15N HMQC titrations of holo-Bamb_5919 ACP with the increasing 
concentrations of Bamb_5919 KS0. The addition of ligand caused some peaks to decrease 
in intensity. The intensity of these peaks did not increase upon addition of unlabelled 
Bamb_5917 PCP, which indicated that Bamb_5919 ACP does not bind in the same location 
on Bamb_5919 KS0. 
 
The analysis showed that the addition of Bamb_5919 KS0 caused intensity decay of some 
of the peaks. However, upon addition of an unlabelled carrier protein there was no 
change in the peak intensity. Again, this showed that Bamb_5919 ACP and Bamb_5917 




Figure 5.2 Figure 0.1 1H-15N HMQC titrations of holo-Bamb_5917 PCP with the increasing 
concentrations of Bamb_5919 KS0. The addition of ketosynthase caused the intensities of 
some of the peaks to decrease. However, they were not recovered upon addition of 
unlabelled Bamb_5919 ACP, which confirmed that Bamb_5919 ACP and Bamb_5917 PCP 






Figure 5.3 NMR Titrations of holo-15N-Bamb_5919 ACP with Bamb_5919 KS0 and 
Bamb_5917 PCP. The intensity decay rates are shown for individual residues. The dilution 
effect was taken into account. The increase in Bamb_5919 PCP concentration (highlighted 
in gray) does not affect the NMR signal decay, indicating that PCP and ACP do not bind in 




Figure 5.4 NMR Titrations of holo-15N-Bamb_5917 PCP with Bamb_5919 KS0 and 
unlabelled Bamb_5919 ACP. The intensity decay rates are shown for individual residues 
and the dilution effect was considered in the calculations. The addition of Bamb_5919 ACP 
(highlighted in gray) does not have an effect on the decay rate of holo-15N-Bamb_5917 
PCP NMR signals, further suggesting that, together with the data presented in Figure 5.3, 




5.3 Comparison of binding interfaces formed by Bamb_5919 ACP, Bamb_5919 
KS0.  Bamb_5917 PCP and Bamb_5915 C 
 
The crystal structure of C domain had been determined by the collaborating prof. Tsai 
group147.  
This crystal structure was used for docking with the NMR structure of Bamb_5917 PCP126.  
The resulting docked complex was used in the chapter to compare the analysed binding 
interfaces.  
Thus, homology model of apo-Bamb_5919 ACP (Figure 3.1) was overlaid to the NMR 
structure of holo-Bamb_5919 PCP, which was docked into the active site of the crystal 
structure of C domain (Figure 5.4). The superposition in Figure 5.4, together with the 
sequence alignments shown in Figure 5.5 and Figure 5.6, revealed that the major 
difference between the two carrier proteins is the length of helix 1. Helix 1 in Bamb_5919 
ACP (20 residues based on the homology model in Figure 3.1) is longer than helix 1 of 
Bamb_5919 PCP (10 residues). Furthermore, the 15N backbone relaxation data and 
TALOS+ analysis discussed in Chapter 3 suggest that helix 1 of Bamb_5919 ACP is even 
longer than predicted from the homology model. A long helix 1 might negatively interfere 
with the likelihood of Bamb_5919 ACP to properly fit into the active site of the C domain 





Figure 5.4 Bamb_5917 PCP docked into Bamb_5915 C139. Homology model of 
Bamb_5919 
Homology model of Bamb_5919 ACP is superimposed with Bamb_5917 PCP. B. Helix 1 of 




Figure 5.5 Sequence alignment between Bamb_5919 ACP and Bamb_5917 PCP. Sequence 
alignment was performed in Clustal. Helix 1 of Bamb_5919 ACP is longer than the same 
helix in Bamb_5919 PCP. 
 
Furthermore, the sequence alignment between the two carrier proteins reveals that 
several amino-acids, mostly in helices 2, and 4 differ significantly in charge (Figure 5.6, 
residues in rectangles). To inspect whether these residues affect the interaction of 
Bamb_5919 ACP with C domain, the Bamb_5919 ACP residues that were affected by the 
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presence of Bamb_5919 KS0 were also shown in Figure 5.6 (red squares, taken from 
Figure 3.30). Majority of the Bamb_5919 ACP residues that were highly affected by the 
binding with Bamb_5919 KS0 were not significantly different in terms of charge or 
hydrophobicity to the aligned residues from Bamb_5919 PCP. This indicated that these 
differences do not explain why Bamb_5919 ACP cannot bind to C domain. 
 
 
Figure 5.6 Schematic representation of the sequence alignment between Bamb_5919 ACP 
and Bamb_5917 PCP. Red squares represent the residues that were affected during 
titrations of Bamb_5919 ACP with Bamb_5919 KS0. Red rectangles pinpoint the residues 
that differ in charge between the two sequences.  
 
 
However, the docking between Bamb_5919 PCP and Bamb_5915 C also showed that the 
C-terminal part of Bamb_5919 PCP aligns with the -hairpin docking domain (HDD) 
located at the N-terminus of C domain of Bamb5915 (Figure 5.8B). The C-terminal part of 
Bamb_5919 PCP is a glutamate-rich intrinsically disordered motif, which is also called 





Figure 5.7 The structure of Bamb_5919 C (A). The beta-hairpin docking domain (βHDD) is 
shown in the figure and highlighted in orange. Bamb_5919 PCP is not shown here. (B) The 
position of SLiM relative to the docking domain with the indicated charged and polar 
residues that might mediate the interaction. 
 
Such linear motifs (usually 3-10 amino acids long) are a common functional module within 
intrinsically disordered proteins. They regulate low-affinity interactions and can target 
proteins to a particular subcellular location, recruit enzymes that alter the chemical state 
of the motif by post-translational modifications (PTMs), control the stability of a protein, 
and promote the recruitment of binding factors to facilitate complex formation162–165.  
The docking domains, such as HDD, are located at the terminal parts of the modules 
within PKSs and NRPSs and mediate the communication between the modules within 
PKSs and NRPSs166,167. More precisely, they are located at the C-terminus of an upstream 
ACP/PCP subunit and the N-terminus of a downstream KS or C subunit.  
These domains are crucial for the interaction and it has been demonstrated that the use 
of genetic engineering to create mismatched docking domains significantly decreased the 
rate of biosynthesis168,169. 
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The charged Bamb_5917 PCP SLiM residues probably establish contacts with the charged 
amino acids of HDD (Figure 5.7), which facilitate the interaction between Bamb_5919 
PCP and Bamb_5915 C.  
Finally, a comparison of the NMR titrations results obtained for the interactions between 
Bamb_5919 PCP and Bamb_5919 KS0 further suggest that the SLiM motif is required for 
the proper interaction between with Bamb_5915 C (Figure 5.8). Figure 5.8 shows that 
the profile of Bamb_5917 PCP residues being affected by the presence of Bamb_5919 
KS0 (Figure 5.8A) and Bamb_5915 C (Figure 5.8B) is similar in helical parts of the protein. 
The titrations of Bamb_5917 PCP and Bamb_5915 were obtained by Dr. S. Kosol. 
However, it is clear that SLiM motif is not affected by the presence of Bamb_5919 KS0. 
Thus, the data suggest that charged residues in SLiM motif are important to establish 
contact with HDD. The C-terminus of ACP is mostly hydrophobic, which might prevent 
it from interacting with the docking domain. It is rather difficult to speculate which type 
of interactions might mediate the interaction between Bamb_5919 KS0 and both carrier 
proteins as the crystal structure of Bamb_5919 KS0 is not complete (the alignment 
between Bamb_5919 KS0 and ketosynthases from other systems is shown in Fig. S-4.5). 
However, the NMR data presented in Chapters 3 and 4 suggests that this might be driven 





Chapter 5 suggests that Bamb_5919 ACP and Bamb_5917 PCP do not bind in the same 
location on Bamb_5919 KS0. The alignment between homology model of apo-
Bamb_5919 ACP and holo-Bamb_5917 PCP docked with Bamb_5915 C indicates that the 
length of Bamb_5919 ACP helix 1 might prevent it from binding into the active site of 
Bamb_5915 C. Furthermore, NMR titrations discussed in Chapters 3 and 4 emphasize 
that the glutamate-rich SLiM motif might make Bamb_5917 PCP a preferential binding 
partner with Bamb_5915 C docking domain HDD over Bamb_5919 ACP, which lacks 




Figure 5.8 The Bamb_5917 PCP residues that were the most affected by titrations with 
Bamb_5919 KS0 (A) and Bamb_5915 C(B). The schematic representation of the alignment 
between the C-terminus of Bamb_5919 ACP and SLiM is also shown. Charged residues are 
highlighted in grey. 
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Conclusions and future work 
 
From the perspective of bacterial cell, incorporation of non-elongating synthases into PKS 
and NRPS pathways might appear to be an energetically costly mechanism of overcoming 
domain-domain interaction incompatibilities. Namely, non-elongating ketosynthases are 
large proteins and their synthesis and degradation is an ATP consuming process. Thus, is 
peculiar that the evolution of biosynthetic pathways was directed towards incorporation 
of such enzymes, instead of mutations of domain-domain interface residues to establish 
favourable interactions. Nevertheless, it seems that non-elongating synthases are utilised 
by a vast number of PKS and NRPS systems to direct the biosynthesis of natural products. 
The work presented in this thesis attempted to understand what particular aspects of 
interaction between the enacyloxin IIa chain termination modules ACP, KS0, PCP and C 
domain can explain the need to employ such ketosynthases. The experimental results 
suggest that the length of helix 1 in enacyloxin module 10 ACP and the absence of specific 
charged residues in its termini may have a negative influence on the propensity to bind 
the downstream C domain. 
Still, many questions remain open and further work will be required to address them. 
Chapter 3 addresses the interaction between Bamb_5919 ACP and Bamb_5919 KS0. To 
analyse the binding interface of Bamb_5919 ACP, it was important to obtain the 
backbone assignment, which was then used to analyse 15N relaxation experiments. 
However, relaxation was only monitored in an unbound protein. It would be also 
interesting to see how the presence of KS0 affects the backbone dynamics of ACP. Next, 
homology model was used as a structure template to solution-state NMR titrations of 
Bamb_5919 ACP with Bamb_5919 KS0. Since the NMR data indicate that helix 1 is even 
longer than predicted from the model, calculating the NMR structure of Bamb_5919 ACP 
would help to  clarify this. 
It was emphasized in the text that Bamb_5919 KS0 is not amenable by solution-state NMR 
spectroscopy and its crystal structure could not be solved at a good enough resolution. 
This poses a problem since the interaction interface formed between KS0 and its carrier 
protein partners cannot be determined. However, a novel approach called carbene 
footprinting could overcome this problem147. This method uses diazirine-based probe to 
label the regions of the protein upon irradiation at 349 nm. Areas of the protein complex 
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that are associated with interactions will remain unlabelled so the interaction interface 
can be mapped even at the residue level126. 
Finally, mutagenesis of specific residues might also provide the information about the 
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Bam_5919 ACP (shorter construct) (from G1626 to P1669)  






Bamb_5919 ACP(longer construct) (from L1614 to A1800) 







Bamb_5919 KS0 (from P1794 to A2463) 














Bamb_5917 PCP (from G215 to the end – R315) 









Figure S.2 LC-MS analysis of used protein constructs. The conversion of apo to holo 

















Figure S.4-1 Dataset 1 - titrations profiles for the peaks disappearing in the NMR titration 
of the 15N-apo-Bamb_5917 ACP with Bamb_5919 KS0. The squares represent peak 
volumes normalised to the peak volume of the apo-Bamb-5919 ACP before addition of 











Figure S.4-2 Dataset 2 - titrations profiles for the peaks disappearing in the NMR 





Figure S.4-3 Dataset 3 - titrations profiles for the peaks disappearing in the NMR 





Figure S.4-4 Dataset 4 - titrations profiles for the peaks disappearing in the NMR 




Table S.1 Chemical shift assignments of apo-Bamb_5919 ACP 
 
Amino acid # H (ppm) N (ppm) C (ppm) C (ppm) 
D tag 8.581 127.061 51.961 41.759 
P tag - - - - 
F tag - - - - 
T tag 7.971 112.861 62.032 69.754 
G 1626 8.484 111.164 45.024 - 
A 1627 8.0 123.532 50.301 - 
P 1628 - - - - 
R 1629 - - - - 
V 1630 - - - - 
E 1631 8.569 125.713 56.203 32.716 
R 1632 8.485 122.746 62.101 32.716 
R 1633 8.485 125.746 55.799 43.174 
A 1634 8.484 126.042 52.500 19.281 
G 1635 8.466 108.220 45.269 - 
G 1636 8.358 108.525 45.304 - 
T 1637 8.125 112.679 61.848 69.700 
A 1638 8.516 126.298 53.095 19.094 
G 1639 8.384 108.168 45.164 - 
A 1640 8.323 123.749 52.679 19.067 
A 1641 8.133 122.415 54.095 19.052 
L 1642 8.155 120.509 57.485 - 
L 1643 7.917 116.413 56.309 42.208 
A 1644 7.704 121.969 52.275 18.125 
G 1645 - - - - 
L 1646 - - - - 
A 1647 - - - - 
S 1648 7.655 110.124 58.786 - 
L 1649 7.324 121.857 53.799 37.269 
D 1650 8.273 119.649 53.099 - 
A 1651 8.635 121.641 56.718 18.240 
A 1652 8.379 120.783 55.081 17.678 
A 1653 8.252 123.531 54.612 - 
R 1654 9.043 119.956 60.106 35.959 
A 1655 8.141 120.765 55.671 17.474 
A 1656 7.872 119.699 55.557 35.448 
R 1657 7.925 118.304 58.356 24.732 
L 1658 8.5 120.427 57.97 - 
K 1659 8.814 121.318 61.385 21.259 
R 1660 7.262 116.907 58.981 - 
H 1661 8.035 120.508 60.435 17.242 
L 1662 8.909 118.499 57.648 41.520 
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E 1663 8.535 118.853 60.857 43.334 
A 1664 7.484 119.130 55.094 - 
A 1665 - - - - 
I 1666 8.577 120.840 61.398 - 
R 1667 7.513 116.6 59.058 43.195 
K 1668 7.778 118.290 59.944 37.813 
L 1669 7.622 122.407 56.726 - 
L 1670 7.741 117.507 55.932 42.349 
N 1671 - - - - 
R 1672 7.94 116.102 54.710 17.781 
A 1673 8.756 124.104 52.163 - 
D 1674 8.514 118.004 52.862 41.112 
T 1675 7.988 114.130 62.810 50.396 
L 1676 8.919 126.635 53.685 43.398 
D 1677 7.974 117.770 54.144 42.193 
D 1678 8.598 125.966 55.809 - 
R 1679 8.487 115.924 55.427 - 
A 1680 8.943 116.092 57.298 63.543 
S 1681 - - - - 
M 1682 9.823 126.621 52.862 40.961 
F 1683 9.020 121.037 57.512 35.969 
D 1684 - - - - 
L 1685 - - - - 
G 1686 - - - - 
L 1687 - - - - 
D 1688 - - - - 
S 1689 - - - - 
L 1690 - - - - 
L 1691 - - - - 
S 1692 - - - - 
I 1693 - - - - 
D 1694 - - - - 
L 1695 - - - - 
R 1696 8.422 119.637 58.007 - 
M 1697 8.449 115.423 58.695 33.236 
Q 1698 8.185 120.218 58.790 - 
L 1699 8.401 118.601 57.88 - 
E 1700 8.248 117.790 59.987 35.948 
K 1701 7.435 118.16 58.888 43.465 
D 1702 8.962 120.278 57.419 36.003 
L 1703 8.254 114.417 53.908 - 
A 1704 7.618 122.332 52.396 19.283 
C 1705 8.096 112.508 55.666 43.032 
S 1706 8.171 114.311 57.298 63.444 
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L 1707 - - - - 
S 1708 - - - - 
T 1709 7.332 120.137 57.770 41.490 
T 1710 8.393 113.543 62.544 20.875 
V 1711 7.407 122.527 65.931 31.004 
L 1712 8.060 118.279 56.720 - 
H 1713 7.335 115.806 58.881 43.452 
D 1714 8.134 117.721 55.679 30.563 
H 1715 7.102 116.630 52.633 40.947 
P 1716 - - - - 
T 1717 - - - - 
I 1718 - - - - 
E 1719 - - - - 
A 1720 - - - - 
L 1721 - - - - 
A 1722 - - - - 
G 1723 - - - - 
F 1724 7.818 122.403 60.572 38.883 
L 1725 8.283 118.282 57.085 42.166 
A 1726 8.283 119.645 55.199 18.533 
E 1727 7.164 115.665 57.532 - 
R 1728 7.572 118.131 56.486 31.278 
V 1729 7.601 115.242 62.611 - 
G 1730 7.935 109.186 44.891 - 
A 1731 7.842 123.952 50.343 18.026 
P 1732 - - - - 
P 1733 - - - - 
A 1734 - - - - 
G 1735 - - - - 
T 1736 - - - - 
V 1737 8.248 123.236 62.321 32.706 
R 1738 7.690 119.921 57.527 40.437 
A 1739 8.032 114.017 54.330 18.739 
G 1740 8.455 108.167 45.558 - 
A 1741 8.155 123.75 53.106 19.385 
A 1742 8.268 123.094 53.866 37.184 
G 1743 8.245 108.483 45.153 - 
G 1744     
A 1745 8.207 123.785 52.630 18.2 
G 1746 8.179 113.194 46.2 - 
A 1747     
G 1748     
T 1749 8.025 114.018 62.144 32.637 
G 1750 8.411 110.943 45.272 - 
A 1751 8.095 124.692 50.287 17.990 
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P 1752 - - - - 
A 1753 - - - - 
G 1754 - - - - 
A 1755 - - - - 
T 1756 - - - - 
G 1757 - - - - 
A 1758 - - - - 
A 1759 8.419 125.999 52.666 19.236 
A 1760 8.264 122.818 52.498 19.064 
A 1761 8.134 122.884 52.424 18.895 
H 1762 8.130 118.220 55.786 30.642 
A 1763 - - - - 
V 1764 8.657 119.276 55.786 30.642 
S 1765 7.133 109.415 57.994 63.647 
S 1766 - - - - 
A 1767 8.292 125.806 52.397 19.694 
S 1768 8.257 117.006 56.313 63.553 





















































Figure S.4-5 Multiple sequence alignment of Bamb_5919 KS0, which was used in the 
project, with the ketosynthase domains with known structures deposited in PDB:  
4MZ0 – Moorea producens (Type I PKS), 2HG4 - Saccharopolyspora erythraea (DEBS 
Module 5, Type I PKS), 2QO3 - Saccharopolyspora erythraea (DEBS Module 3, Type I PKS), 
5ELP - Bacillus amyloliquefaciens (Module 1, Type I PKS), 4NA2 – Bacillus subtilis (Type I 
PKS), 5ERB - Bacillus amyloliquefaciens (Module 5, Type I PKS), 4Z37 - Brevibacillus brevis 
(Type I PKS), 1TQY - Streptomyces coelicolor (Type II PKS), 5KOF - Escherichia coli (Type II 
FAS). Bamb_5919_KS0 represents Bamb_5919 KS0 sequence used in the project. 
Conserved catalytic triad residues are highlighted in orange. 
